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ABSTRACT OF DISSERTATION 
UNDERSTANDING THE NATURE OF MEDICATION ADHERENCE ISSUES WITH 
THE HIV INFECTED PATIENT IN THE FAMILY PRACTICE SETTING 
One of the greatest challenges in managing the medication therapy in any chronic 
disease is how to influence human behavior, such as adherence to antiretroviral therapy in 
the Human Immune Virus (HIV) positive patient. Although data demonstrate significant 
viral suppression and immunologic benefits of therapy when taking antiretroviral 
medication at a 95% adherence, non-adherence remains a problem in the HIV or 
Acquired Immune Deficiency Syndrome (AIDS) population. Past literature indicates it 
may relate to the quality of information given, the impact of the regimen on daily life, the 
physical or the incapacity of patients, or their social isolation. 
This is a basic qualitative research study. The purpose of this study is to have a 
basic interpretive qualitative understanding of the nature of non-adherence to mediation 
in the HIV infected patient in a family practice setting. During interviewing, each 
participant had their own personal story about being HIV positive and why they adhere or 
do not adhere to their medication regimen. It appears that adherence to any highly active 
antiretroviral therapy (HAART) revolves around the well being and the understanding of 
lifelong commitment of the HIV patient. A hypothetical model has been constructed 
relating the Health Belief Model to HIV medication adherence as found in this study. The 
educational opportunities for the HIV infected person have improved over the past 10 
years. Many private and government organizations provide training and learning 
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materials and the healthcare providers are more aware of the needs of the HIV positive 
person. The lifestyles ofHIV positive people are no different then the non-infected 
person. However, the side effects of the HAART have been shown to affect the 
adherence. Seeing HIV in a more positive light contributes to the well being of the 
infected person. Patients find it easier to cope with their disease if they see it as an 
opportunity for personal growth or can attach some other positive meaning to it. The 
outlook on HIV disease has gone from a death sentence to one of guarded optimism. It is 
viewed as a life long commitment. 
Peter Thomas Prutch 
School of Education 
Colorado State University 
Fort Collins, CO 80523 
Summer2005 
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CHAPTER 1: INTRODUCTION 
"It is more important to know what type of patient has a disease than what type of 
disease a patient has" (Sir William Osler, as cited in World Health CME, 2003). Highly 
active antiretroviral therapy (HAART) for the treatment of Human Immune Virus (HIV) 
and Acquired Immune Deficiency Syndrome (AIDS) can be incredibly con1plicated, with 
three to four different medications, many doses per day and a myriad of additional dosing 
rules and restrictions. Yet, despite the complex nature of these regimens, it is essential 
that patients take them consistently, and exactly as prescribed. Failure to maintain the 
necessary "adherence" to the prescribed regimen leads to therapeutic failure of the 
treatment regimen. Given this pivotal role that adherence plays in the success of HIV 
treatment, HIV I AIDS treating healthcare providers need to be knowledgeable regarding 
key strategies for enhancing their patients' adherence to HAART and comfortable 
utilizing these strategies in a family practice clinic. 
Before one can understand the nature of non-adherence and adherence to HIV 
medication, one must understand the disease itself, and its history. Where did HIV 
originate? HIV is very closely related to Simian Immune Virus (SIV) found in 
chimpanzees. Apes can be infected with HIV, and they can also suffer from a version of 
SIV (Randerson, 2002). During the 1999 Sixth Annual American Conference on 
Retroviruses and Opportunistic Infections the keynote address, delivered by Beatrice 
Hahn, stated HIV is likely to have originated in West African chimpanzees. HIV could 
have been transferred from monkeys to humans; mainly because, when hunting monkeys, 
it is not unusual for both the hunter and the hunted to exchange blood during the capture 
(Uhavax, 2003). 
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Some scientists believe HIV spread from monkeys to humans sometime between 
1926 and 1946. The earliest fully documented case ofHIV dates back to 1959. A man 
died in the Congo in what researchers now say was the first proven AIDS death. A frozen 
blood sample from the medical study was preserved, found, and then analyzed in 1998. It 
was verified that he had been HIV positive. It has also been claimed that the disease 
originated from African green monkey kidneys. The kidneys were used to cultivate 
poliovirus in the late 1950s and early 1960s. According to Uhavax (2003), this theory has 
a low probability. 
The first recorded cases in the United States occurred in New York City in 1952, 
1959, and 1979. By 1978, gay men in the U.S. and Sweden and heterosexuals in Tanzania 
and Haiti began showing signs of what would later be called AIDS (AEGIS, 2001). The 
term AIDS was not introduced until 1982. The Food and Drug Administration (FDA) 
approved the first HIV antibody test in 1985. All blood products in the U.S. and Japan 
began to be tested for HIV. President Ronald Regan refused to mention the word "AIDS" 
in any public speech, so in 1986 the U.S. Surgeon General Everett Koop published a 
report on AIDS and made the first public speech on the subject. By then, the HIV I AIDS 
epidemic was in full force. Koop announced the importance of sex education and "safe 
sex." It was not until 1987 that President Reagan would use the word AIDS in public 
(Uhavax, 2003). 
In 1987, zidovudine (AZT) became the first anti-HIV drug approved by the FDA. 
HIV drugs are designed to fight the disease process. The recommended dose was one 
1 OOmg capsule every four hours around the clock. Between 1987 and 2003, there were 22 
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additional FDA approved anti-retroviral drugs added to the course of treatment for HIV 
(Bayer, 2000). Unfortunately, all these medications have side effects such as 
nausea/vomiting, severe fatigue, and nightmares. Combination drug therapy was 
introduced in the early 1990s and continues today. Most HIV infected patients receive a 
combination of three or more anti-retroviral medications, hence the name "drug 
cocktails." Although the regimes or cocktails have simplified over the years, it is still not 
unusual for an HIV infected person to take 8 to 10 medications, two to three times a day. 
With the large pill burdens and toxic adverse effects of the antiretroviral prescriptions, it 
is difficult to convince the patient to adhere to their medications. Research needs to be 
done regarding medication adherence, especially in the family practice clinic. 
A family practice clinic is a medical specialty in which general medical care, 
counseling and problem solving is provided to an individual or family, without regard to 
age or as to whether the patient is male or female. Family practice is a broad area and 
ranges from work with infants to caring for people who are dying ( Evergreen Health 
Care, 2005). 
Need for the Study 
Adherence to antiretroviral therapy is a crucial determinant of treatment success. 
John Bartlett, from the University of San Francisco, has unequivocally demonstrated the 
close association between adherence and plasma HIV ribonucleic acid (RNA) levels, 
CD4 cell counts, and mortality in-patients with HIV infection and disease. Adherence 
levels of greater then 95% are required to maintain virologic suppression. Nevertheless, 
actual adherence rates are often far lower. Studies have shown that 40% to 60% of 
patients are less then 90% adherent (Chesney, 2000). Adherence also tends to decrease 
over time. Patients offer a range of reasons for non-adherence, but the most frequently 
cited one is simply that they forget. Other reasons include being away from home, being 
busy, or experiencing a change in daily routine. Additional barriers to adherence include 
psychiatric disorders, such as depression or substance use; uncertainty about the 
effectiveness of treatment and the consequences of poor adherence, regimen complexity, 
and treatment side effects. There is a need for this study due to the lack of HIV research 
in the family practice clinic setting, particularly regarding HIV medication adherence. 
Statement of Research Problem 
4 
The lack of adherence to HIV medications have lead to further complications 
regarding the disease process. Estimates of average rates of non-adherence to an 
antiretroviral therapy range from 50% to 70%. Adherence rates of 80% are associated 
with detectable virus in patients (Bartlet, 2002). The purpose of this basic interpretive 
qualitative research study will be to explore the nature of non-adherence to medication in 
the HIV infected patient in a family practice clinic setting. 
Research Questions 
Grand tour question: What issues need to be addressed in order for the HIV 
positive person to adhere to their medication regimen in a family practice setting? 
1. What educational opportunities were available to the participants concerning their 
drug therapy? 
2. What is the participant's day-to-day lifestyle, including routine schedule? 
3. What side effects ofHAART most concern the participants? 
Definition of Terms 
Adherence. Routinely taking a prescribed medication at least 95% of the time. 
Antiretroviral medication. Medications that help control HIV I AIDS. 
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Educational opportunities. Any learning tool or tools needed by the participant to 
help understand their disease and potential complications. 
Family practice setting. Medical clinic that cares for all ages. The primary 
healthcare provider in this setting is the primary person who gives the medical care to the 
patient. This could be a doctor, physician's assistant or nurse practitioner. 
Highly active antiretroviral therapy (HAART). Taking three or more antiretroviral 
medications. These medications can be administrated one to four times a day and include 
between 3 to 14 pills at a time. 
HIV positive person. Any person who is infected with the Human Immune Virus. 
Medication regime. Taking a prescribed medication on a routine base, basically at 
the same time daily. 
Protease Inhibitors (PI). These Medications prevent the enzyme protease from 
cleaving or cutting up the newly formed viral precursor proteins into viral structural 
proteins and enzymes. 
Side e_ffects of medication. Any adverse reaction to the prescribed medication. 
Significance of the Study 
In a survey of the literature, no studies were found that took place in a Family 
Practice Clinic setting. This study takes place in the family practice setting where the 
participants have their healthcare needs met by the same healthcare provider. Because 
most of the healthcare needs of the participants are met in this setting, the health care 
provider has the benefit of understanding what other issues may be impeding the 
adherence to their medication regimen. Additionally, this study comes at a time where 
several new antiretroviral medications are being approved by the Food and Drug 
Administration (FDA). Some of these newer medications have few side effects, and the 
daily dosing of medication can be less frequent (Bartlett, 2003). 
This study will aid future and possibly present research in other family practice 
clinics or other small health care clinics that are interested in HIV care. 
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Investigator's Perspective 
This researcher has been a registered nurse for 24 years and a nurse practitioner 
since 1996. This researcher has been working with HIV positive patients for many years. 
I have observed many patients successfully adhere to their strict medication regimen and 
live healthy lives. However, I have also observed HIV positive patients who do not 
adhere to their medication regime and suffer the consequences. I feel the healthcare 
provider in a family practice clinic has a better understanding of the HIV positive 
person's health care needs because they not only work with the health care issues of HIV, 
but all healthcare issues. I believe patient education is the most important aspect to 
anyone's good health. Adherence to medication is an essential part of life for HIV 
positive people and essential to prevent disease progression. 
CHAPTER 2: LITERATURE REVIEW 
Medication adherence is the degree of correspondence between the patient's 
actual dosing history and the prescribed regimen. The concept of adherence denotes a 
collaborative, interactive, patient-clinician relationship (Meredith, 1999). According to 
Lisabeth Hall ( 1999) in the United States medication non-adherence causes an estimated 
125,000 deaths annually, a loss of20 million workdays and $1.5 billion in earnings. Non-
adherence is the cause of I 0% of hospital admissions, and $8.5 billion in excess 
hospitalization costs. In addition, about 39o/o of all adverse drug reactions necessitating 
hospitalization are a consequence of the improper use of medication (Hall, 1999). When 
the medication the healthcare provider prescribes fails to produce the benefit he expects 
he often responds by changing the medication. Thus, the healthcare provider puts the 
blame on the medication rather than the patient. Although it is known that about half of 
the medicines prescribed for patients with long-term conditions are not taken as 
prescribed, the concerns of health professionals have focused almost exclusively on 
improving the quality of their own prescribing choices. Yet non-adherence continues to 
represent a serious therapeutic deficit at the core of medical practice, with consequent 
massive personal, societal, and economic cost (Marinker, 2003). 
Patients may not comply with a medication regimen for many reasons. Non-
adherence may be intentional or involuntary. According to Haynes (1996), adherence 
may relate to the quality of infom1ation given, and the impact of the regimen on daily 
life, the physical or the mental incapacity of patients, or their social isolation. Many 
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interventions to overcome these impediments have been tried, but evidence of sustained 
success is scant. 
Medication adherence is an integral part of healthcare for patients with chronic 
conditions. Non-adherence not only causes negative clinical outcomes, but it can also be 
costly for patients and healthcare organizations (Col, 1990). Unnecessary hospitalization 
and emergency department visits related to poor adherence cost as much as $100 billion, 
annually (Lewis, 1997). Overdosing is uncommon, but delayed doses, missing a single 
dose, and missing more than one dose are the most common adherence problems. 
Another common adherence problem is when a patient misses doses for an extended 
period, then resumes taking the medication at full dose. This behavior can cause toxicity 
and adverse effects (Urquhart, 1999). 
Characteristics of Adherence and Non-adherence 
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Medication adherence is measured by the number of doses taken and the impact 
on the medical diagnosis (Elder, 2000). Non-adherence to medication regimens is 
common, especially with long-term therapy. It is a serious, but potentially correctable 
cause of treatment failure and adverse drug-related complications resulting in 
hospitalization and even death among older adults. Reasons for non-adherence among the 
elderly are incompletely understood but include complex mediation regimens, age-related 
disease and disability, frank or subtle cognitive impairment, poor understanding of 
medication use, and inadequate patient-provider communication (Durson, 2001). 
In 1990, Dr. Nathan Col demonstrated only a vague relationship between 
medication non-adherence and socioeconomic status, gender, or marital status, however, 
people with financial constraints or lack of insurance may not fill prescriptions or return 
for follow-up office visits. 
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During the first few months, treatment for a chronic condition has a high 
discontinuation rate; consequently, the early treatment period is an opportune time to 
identify adherence problems. Failure to begin a regimen and early discontinuation may be 
linked to patient perceptions that the treatment has limited benefits or did not help them. 
Patients who experience adverse effects are more likely to discontinue treatment, 
however, advising patients of potential adverse effects neither increases the complaints of 
adverse effects nor prevents medication adherence (Park, 1999). 
To some extent, patients and physicians work at cross-purposes when it comes to 
medications, states Dr. Steven Goldfinger (as cited in Park, 1999) at a meeting on mental 
health sponsored by the University of Virginia. 
Don't be surprised when patients don't take their medicines. Pills don't work if 
you don't take them. Often, physicians are busy trying to titrate the dose of 
medication to improve symptoms, only to find out from blood analysis that 
patients aren't taking any of them. The core of the matter is that we care about 
effects and our patients care about side effects. Physicians only ask about side 
effects that they care about. They don't ask about sexual side effects, weight gain, 
or other side effects that are important to the patients. In fact, medications do not 
have effects and side effects. They only have effects. Diphenhydramine is the 
perfect example. If you take it because you have a runny nose, the fact that it 
makes you drowsy is a side effect. If you take it because you can't sleep, the fact 
that makes you dry is a side effect. (p. 350) 
From the patient's perspective, there is a spectrum of acceptability of therapy. 
Medications that have an immediate desired effect without side effects are medications 
that patients want to take. Medications that have little perceived effect and few side 
effects are less likely to be taken by patients. Medications that have delayed or unwanted 
side effects and that, in the patient's perspective, treat symptoms that patients don't think 
they have are very unlikely to be taken by patients (Wachter, 2003). 
Although knowledge of disease processes does not aid adherence, patients who 
understand the purpose of a drug and how the drug is to be taken are more likely to take it 
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as prescribed. A patient's belief in the efficacy of the medication and faith in his ability to 
take the medication as prescribed is also critical. Patients are more likely to adhere to a 
regimen when the relationship with their healthcare provider allows them to express 
concerns about a condition or treatment, when treatment goals are shared, and when plans 
are made to over-come identified barriers (Schaffer, 2001 ). 
According to Cohen (2003), at least half of all people stop taking their blood 
pressure medications because of the side effects that typically include fatigue, lethargy, 
dizziness, and sexual dysfunction. Cohen states he knows why people do not adhere to 
blood pressure medication, "The dose is set too high" (p. 5). He takes issue with the 
prevailing belief among doctors and drug manufacturers that side effects are inevitable 
and unavoidable. In his book, Over Dose: The Case Against Drug Companies, Dr. Cohen 
says that the drug companies set the dosage for all prescription drugs at a high level 
because it is more convenient for doctors and not the patient. Thus, drug side effects 
occur, causing poor adherence to the medication regimen in the hypertensive patient 
(Cohen, 2003). 
To determine medication adherence and predictors of sub-optimal adherence in a 
community cohort of patients with diabetes and to test the hypothesis that adherence 
decreases with increased number of medicines prescribed, Richard W. Grant and 
associates conducted a 30 day study using 128 diabetic patients, with the average patient 
taking a mean of 4.1 diabetes-related medicines daily. In Grant's (2003) sample, patients 
reported very high medication adherence rates regardless of the number of medicines 
prescribed. Moreover, a higher number of prescribed medicines were not associated with 
poorer per-medicine adherence. Rather, patients with suboptimal overall adherence 
tended to have problems with one specific medicine out of their overall medical regimen. 
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Among patients on three or more diabetes-related medicines, Grant found the majority of 
those patients with less than perfect adherence did take at least one medicine faithfully. 
Correlates of poor adherence included problems with side effects and a lack of conviction 
on the patient's part that the medicine was helping either current symptoms or future 
health. 
New research presented at the annual meeting of the College of Psychiatric and 
Neurological Pharmacists demonstrates that failure to consistently take medication 
increases the risk of hospitalization in patients with schizophrenia, with a direct 
relationship between days missed and risks (Manisses Communication Group, 2003 ). The 
12-month study examined prescription records for 4,325 patients with schizophrenia who 
were enrolled in the California Medicaid system. The main reasons given for poor 
adherence to medications were the side effects of the drugs and inconvenient regimes 
(2003). 
According to a national survey of 661 patients, even epilepsy patients miss 
medication doses Kim (2003). The survey found that 71% of the epilepsy patients 
acknowledged missing at least one dose of medication in the last month. Perhaps the 
most relevant finding of the study was that 45% of the patients overall reported that they 
experienced a seizure related to missed medication at some time in the past. Analysis of 
the data revealed that the longer a patient had taken epilepsy medication, the more likely 
he or she was to have missed a dose at some time. It also found that the greater numbers 
of different medications taken, and the more frequently the epilepsy mediation had to be 
taken, were closely related to missed doses. The odds of missing a dose increased by 27o/o 
for each increase in the number of times a patient had to take medication in a day. The 
number of pills a patient had to take in a day was not found to be related to missed doses. 
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Patients who do not adhere to a regimen for antidepressants have several defining 
characteristics. The preliminary results of a survey of 1 02 outpatients from the practices 
of 20 Northwest Ohio primary care physicians showed that non-adherent patients appear 
to be younger, unmarried, and less educated than those patients who adhere to an 
antidepressant regimen. Of the 102 patients who were in the study, 86% were adherent, 
which meant that they had been compliant all or most of the time during the previous four 
weeks with their antidepressant regimen (Evans, 2003). 
Asthma is the most common chronic disease in childhood, and it continues to be 
associated with high rates of morbidity and mortality despite improved treatment 
protocols. Lack of adherence to individual treatment plans has been implicated in these 
poor outcomes. Divertie (2002) conducted a study to identify obstacles that might limit 
adherence to asthma treatment and offer practical suggestions for promoting adherence in 
pediatric patients. The reasons children fail to adhere to individual treatment plans 
include financial barriers, misconception about asthma, cultural influences, and mistaken 
health beliefs. In addition, family education about asthma management can be inadequate 
without an efficiently run asthma program, which includes telephone access to the 
provider. By eliminating barriers to adherence, maintaining open communication, and 
consistent positive support children with asthma can maintain the highest quality of life. 
Reviewing all five chronic diseases: hypertension, diabetes,epilepsy, mental 
health and asthma it is clear that adherence to the medication regimen is critical, yet 
studies show non-adherence is common. Serum drug levels help measure non-adherence 
but not for all drugs. The medications taken for the treatment of all four chronic diseases 
have side effects and are inconvenient to take, and do not fit into the day-to-day lifestyles 
of many patients. 
13 
Psychological Theoretical Framework of Adherence 
Golin's (Golin, et al., 2001) meta-analysis focused on understanding the 
immensely complex phenomenon of patient's adherence to medical treatment. Empirical 
studies since the late 1960s have raised many questions, some of which remain 
unanswered in spite of decades of research and a variety of study designs, including Meta 
analytic methods and multidimensional models. Both of these methods have contributed 
important results and usually they tell the same story. It is important to recognize that 
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fully understanding the role of adherence in treatment outcomes requires further analysis 
of the conceptual and methodological factors that affect this relationship, and future 
research on adherence would do well to provide quantitative data to further this 
examination. Evidence from the present study complements findings from intervention 
research to suggest that patient adherence is linked to more positive outcomes than is 
non-adherence, and thus, adherence may be a valuable goal of intervention. 
Angela Hausman (200 1) studied the impact on patients' compliance with 
physicians' instructions of ( 1) open communication between the patient and physicians; 
(2) impersonal communication through prescription drug advertising; (3) participation of 
patients in determining treatment options; and ( 4) the interactions of these constructs. A 
convenience sample of 239 patient-respondents was obtained. 
The importance of communication, both as a form of information exchange and 
social support, and of participative decision making, improves patient compliance. These 
results, based on structural equation modeling, also support the interaction of 
communication and participative decision-making positively affecting compliance. 
Frequency analysis shows that drug advertising is highly effective in increasing 
awareness of the product, but few patients surveyed discussed the advertised drug with 
their physician (200 1 ). It is concluded that one-way communication from physician to 
patient and patient education will not solve adherence problems by themselves. Instead 
the solution revolves around open, bi-directional information exchange, active listening 
by both parties, and truly informed consent on the part of patients. 
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Doctors DiMatteo, Giordani, Lepper, and Croghan (2002) conducted a study that 
reviewed three decades of research on patient adherence and the outcomes of treatment 
using the techniques of meta.:analysis to combine effects from more than 19,000 patients 
in 63 studies. On average, 26% more patients experienced a good outcome by adhering 
than by not adhering to prescribed treatment regimens, a slightly stronger effect than in a 
study of the outcomes of adherence-enhancing interventions and similar to a recent 
focused review on adherence and heart disease outcomes. The strength of these effects 
suggests that the behavioral phenomenon of adherence may be as important to outcomes 
as many well established medical interventions. 
Factors, such as the efficacy of recommendations and treatment, genetic 
variations in response rates, and limitations in current understanding of disease can affect 
outcomes. In some cases, such as when misdiagnosis, adverse drug reactions, or 
prescribing errors occur, adherence to recommended treatment could be harmfuL The 
conceptualization and operationalization of measurement appears to be critical to 
understanding the adherence-outcome relationship. Reverse causality may also play a 
role, so that a good outcome may promote subsequent adherence. It is also important to 
consider the perspectives of patients, many of who may view non-adherence as a rational 
choice (Donovan, 1992). 
Factors that modifY the adherence-outcome relationship, particularly those 
involving the nature of diseases and of patients, appear to be extraordinarily complex. For 
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example, the adherence-outcome relationship is higher in studies of chronic diseases than 
in studies of acute conditions. One possible explanation is the illness might be more self-
limiting, making adherence less important than in long term care, although several of the 
moderators were intercorrelated. Chronic conditions involved more non-medication 
regimens, were less serious, and were more likely to use continuous measures of 
adherence, all factors associated with higher adherence-outcome correlations. The 
adherence-outcome relationship was also higher for pediatric patients compared with 
adults, po;;sibly because of the less serious medical conditions represented in the pediatric 
samples or because parental adherence behavior may have been accompanied by 
additional care-taking that promotes better health outcomes. Conversely, the achievement 
of good outcomes might be more difficult in adults because of co-morbid conditions or 
long standing poor health habits. This result could also be an artifact of differences 
between the two groups in their outcome measures. The adherence-outcome relationship 
was lower in studies of more serious conditions, a finding that could be explained by this 
variable's correlation with other moderators, or by the possibility that patient adherence 
behavior makes a greater difference under less extreme medical circumstances 
(DiMatteo, 2002). 
Overall, the outcome difference between high and low adherence is 26% (Golin, 
2001 ). According to stringent random effect models, adherence is most strongly related to 
outcomes in studies of non-medication regimens, where measures of adherence are 
continuous, and where the disease is chronic. Inter-correlations among moderator 
variables in multiple regression show that the best predictor of adherence-outcome 
relationship is methodological, the sensitivity/quality of the adherence assessment (Go lin 
et al., 2001 ). 
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HIV Medication Non-Adherence and Adherence Issues 
Taking medication as prescribed is particularly critical for AIDS patients, and the 
ramifications of not taking medications as prescribed have serious consequences. 
Jones (2002) conducted a qualitative study of nine HIV positive patients to explore the 
experience of daily life of taking combination drug therapy, or HARRT. The purpose of 
the study was to gain a better understanding of factors relating to HIV medication 
adherence and non-adherence. Implementation of the study and analysis of the data were 
done using an integrated method for conducting phenomenological research. Face-to-face 
in-depth interviews were conducted using three women and six men who were HIV 
positive. The participants acquired HIV thru occupational exposure, sexual transmission, 
and contaminated blood products. All nine were taking HIV antiretroviral medications in 
various combinations. Analysis of all nine interviews revealed six major themes that 
described the day-to-day experiences in taking their HIV medications. The six themes 
were: becoming a patient, managing and being managed by the medications, coping with 
the medications, feeling lousy, negotiating the hassles and the cost, and living under a 
dark cloud (Jones, 2002). 
Flaherty (2003), in a small Chicago study, suggested that attitudes about HIV and 
AIDS among HIV -infected people can be broken down into types that are predictive of 
how well the patients will adhere to their mediation regimens. If the study's findings are 
confirmed in a larger cohort, then it will soon be possible for HIV clinicians to predict 
which HIV patients will have the most difficulty taking their mediations based on their 
presenting attitudes about HIV disease. 
It's pretty clear to me that adherence is the key, at least in affluent societies like 
ours that have access to antiretroviral medication. The people who do well over 
the long haul are different from those who don't do well, principally on the basis 
of being able to take their medications. I think we spend most of our time in the 
clinic on that issue with patients (p. 3 8). 
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What HIV clinicians might sense from their experience with HIV patients is that 
some patient personalities and attitudes appear to do much better in adhering to 
antiretroviral regimes. Rachel Power ( et al., 2003) examined the relationship of 
adherence to antiretroviral treatment with three types of social support (partner, friends, 
and family) and use of two coping strategies (denial and substance use). Seventy-three 
men and women with HIV infection were drawn from a larger sample of 186 clinical trial 
patients. Based on inclusion criteria, patient trial participants taking antiretroviral 
therapies and those with complete data on self-reported measures of adherence were 
considered eligible for the study. Overall, 26% of participants where found to be non-
adherent, which were defined as one or more missed doses of treatment in the prior 4-day 
period. Logistic regression analysis was conducted to determine the association of social 
demographic and psychosocial variables with adherence to antiretroviral regimens. 
Results indicated that heterosexual participants and participants of Latino ethnicity were 
significantly more likely to report missed medications. Perceived satisfaction with 
support from a partner was associated with taking antiretroviral therapy as prescribed, 
whereas satisfaction with support from friends and from family was not significantly 
related to adherence. Examination of coping strategies showed that participants reporting 
drug and alcohol use to cope with HIV -related stress were more likely to be non-
adherent. These findings call for adherence interventions designed to address barriers and 
strengths, such as community norms or traditional cultural values, specific to certain 
populations. Furthermore, couple-based approaches enlisting the partner's support may 
help persons living with HIV to adhere to antiretroviral regimens (Power et al., 2003). 
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Social support was also found to play a small but potentially important role in 
helping HIV -positive people adhere to the complicated schedules for taking their drug 
"cocktails." Simoni (2003) conducted a pilot study of primarily indigent Black and 
Puerto Rican men and women at an HIV clinic in New York City. The study suggested 
that individuals who had the social support they needed were more likely to take their 
mediations. The pilot project was part of a larger study to assess the efficacy of peer 
support to enhance people's adherence to their cocktail or HARRT. "Social support can 
be as simple as having someone ask if you took your pills today," said Jane Simoni. In 
the study, patients were asked specifically about their need in the past month for other 
people (including friends, professionals or those they live with) to bolster their self-
efficacy and to provide information, advice and suggestions about their medications. 
"Highly active antiretroviral therapy was first touted as a cure for AIDS, but it is difficult 
to take the medications and to take them at the rate needed to control the virus. But this is 
not the first time in history people haven't taken their medicine. Even if we did the 
perfect vaccine or pill, or magic bullet, people still would have to take it. So adherence 
would still be a problem" (p.2). Jane Simoni's pilot study, self-reported data from 50 
people, indicated that they took 85% of their medications over the previous 3 days. 
However, the rates of compliance dropped off sharply when they were questioned more 
closely about taking the correct number of pills, following dosing schedules and other 
special instructions. The study showed as many as 60% of people taking the antiretroviral 
cocktails adhere to their medication less than 90% of the time. Dose effect studies 
indicate HIV positive people need to take their medicine at least 95% of the time. 
Simoni (2003) stated that the daily regimen for the cocktail is not quite as 
complicated today as it was when the therapy was first introduced. However, the side 
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effects of the medications remain, and people may experience vivid nighttnares, 
headaches, nausea, diarrhea, rashes, altered liver functions, change in their body's fat 
distribution and elevated cholesterol levels. Simoni also states the most common reasons 
given for not taking medications were "I just forgot" by 50% of the patients and '"I felt 
worse when I took the pills" by 46%. 
Another group of clinical investigators conducted a similar study that evaluated 
adherence and rates of virologic failure/success in 886 antiretroviral-treatment-nai've 
patients beginning triple combination therapy (Low-Beer, 2000). Adherence was 
estimated by monthly prescription refill data. As with Paterson, they found a significant 
linear trend of improved virologic suppression across adherence categories, with at least 
95% adherence associated with high rates of virologic success. In this observational 
study, 84°/o of patients who were 95% adherence had HIV RNA less than 500 copies per 
milliliter, whereas only 64% of patients who were between 90-94% adherent had HIV 
RNA less than 500 copies/per milliliter (Low-Beer, 2000). 
Gifford (2002) also reported on the relationship between self-reported adherence 
and plasma HIV-1 RNA concentrations among 133 HIV infected adults receiving 
antiretroviral therapy. While the method of adherence measurement and the examination 
of virologic response differ from those used in Paterson and Low-Beer, this study also 
reported a significant relationship between adherence and the level of viral suppression. 
He also reported that adherence was poor (less than 80%) 28%, fair (80%- 99%) in 23%, 
and excellent ( 100%) in 50% of study subjects. Mean decreases in Plasma HIV- RNA 
from highest ever levels where 1.3, 1.6, and 2.0 in the three groups, respectively 
(p<0.02). 
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The study known as the Trilege study (as cited in Descamps, 2000), an analysis of 
pill counts, resistance assays, and drug plasma levels, suggested that non-adherence was 
the cause of viral rebound rather than lack of antiretroviral potency or development of 
resistance mutations. The Trilege study was an induction-maintenance study that 
evaluated the efficacy of three maintenance regimens that followed an initial induction 
therapy of three drugs. Patients were randomized to continue their initial induction 
therapy, or receive dual therapy with one additional drug. All but two patients failing the 
triple regimen had undetectable drug plasma levels. This study suggests that non-
adherence, rather than lack of potency ofHAART, can often explain early treatment 
failures. 
HIV I AIDS is a chronic life threatening disease. Like other chronic diseases the 
treatment requires long-term medication therapy. Also, like other chronic diseases, 
people are not always adherent to their medication regimens. Several well-known 
infectious disease specialists have studied this problem. Yet non-adherence remains a 
problem. 
Strategies for Adherence for HIV Positive Patients 
Several strategies can be employed in the effort to support patients' adherence, 
and all members of the multidisciplinary team should, ideally, employ these strategies in 
combination. Efforts should be made to educate and motivate the patient, simplify 
treatment regimens and tailor them to individual lifestyles, prepare for and manage side 
effects, and address the concrete issues that may be a barrier to adherence. Recruiting an 
adherence monitor, providing memory aids for medication taking, and anticipating course 
corrections can also help patients achieve the adherence rates needed for successful 
treatment of HIV infection and disease (Bartlett, 2002). 
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Measurement of adherence may be important in determining why patients fail 
antiretroviral therapy. Although patient self-reports are by far the most frequently used 
means of assessing adherence, self-reporting overestimates adherence. However, patients 
who state they are non-adherent almost always are. The pill identification test is a 
recently described tool that may be useful in clinical practice. The best methods of 
adherence measurement are pill counts and electronic monitoring. Pill counts suffer from 
an inability to record the time of consumption of therapy. Electronic monitoring enables 
timing of pill consumption and is the closest to a gold standard for measuring adherence. 
However, this is only the case if patients are carefully instructed in how to use the device, 
e.g., not to remove extra doses from their pill bottle (Paterson, 2002). 
Cederfjall (2002) studied the relation between self-reporting adherence to 
antiretroviral treatment and degree of sense of coherence in a group of HIV positive 
patients. Ninety-nine patients were from an outpatient clinic, all undergoing antiretroviral 
therapy. Questionnaires were answered twice at a 12-month interval. The 29-item Sense 
of Coherence (SOC) scale was used for measuring the ability to cope with stressful life 
situations. Medication adherence was assessed with self-reported measurements. Clinical 
characteristics and background variables were collected from the medical records. 
Results from variables measured with the 12-month intervals show a significant 
concordance with disease stage and in HIV 1 RNA copies per milliliter and an increase in 
CD4 cell count. The analysis showed significant differences between non-adherent 
patients and adherent patients at the last measurement, (i.e., the non-adherent group had 
lower CD4 cell counts and higher HIVl RNA levels than the adherent group). Finally, 
multiple regression analyses showed that at measurement 2 the SOC predicted non-
adherence, the lower the SOC the more missed doses. Because SOC seems to play an 
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important role in this group of patients managing their disease, a caring patient-provider 
relationship should be developed to minimize non-adherent behavior. For this reason, 
Cederfjall (2002) suggests the SOC scale might be of great clinical value to identify 
patients needing the most support for successful treatment. 
Kathleen Johnston Roberts and Paul Volberding (1999) conducted a study in 
which they explored how HIV I AIDS care physicians communicated with HIV positive 
patient about the need for adherence to antiretroviral treatment regimens. The study was a 
face-to-face interview, qualitative research method with fifteen physicians, and most of 
which were board certified in internal medicine and I or infectious diseases, all were 
involved in HIV continuity care. 
Roberts and Volberding' s ( 1999) research results concluded that most physicians 
engaged in both pre- and post- prescription phases of adherence communication with 
their patients. During the pre-prescription phase, physicians made decisions about 
offering prescriptions to patients, often based on their beliefs about the patient's 
likelihood of adhering to therapy. During the post- prescription phase, physicians asked 
patients how they were adhering to the regimens. Physicians' practices, such as the length 
of time spent in the pre-prescription phase, the timing of the check-ins in the post 
prescription phase, and the overall content of both phases varied significantly. 
Physicians have diverse ways of communicating with patients regarding 
adherence to antiretroviral medications. The effect of such communication on treatment 
outcome needs to be assessed; however, the potential benefit suggests that training 
programs should be developed to improve physicians' skill in this area. 
Physicians estimate their patients' adherence to medications, and base decisions 
about treatment on these estimates. In HIV, misjudgment of patient adherence can have 
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adverse consequences, including withholding of therapy, unnecessary changes in therapy, 
or unnecessary laboratory testing. A review of the literature demonstrates physicians are 
often inaccurate in estimating patient adherence with antiretroviral therapy. These 
findings have implications for practice. Standardized methods for adherence assessment 
are currently available that can be used to enhance physicians' ability to understand 
adherence behavior and barriers. The patient-physician relationship presents a unique 
setting for improving adherence. Improved communication, including discussion about 
patient lifestyle and preferences, can facilitate a frank exchange of information, 
negotiation, and a spirit of cooperation. Active patient participation in the decision-
making process is crucial (Murri, 2002). 
Rapid advances in biomedical science, such as pharmaceutical developments for 
HIV disease, must be integrated with advances in behavioral science to further our 
understanding of medication adherence. Adherence is a complex dynamic behavior 
influenced by characteristics of the patient, treatment regimens, disease, patient-provider 
relationship, and clinical setting. Therefore, the most promising interventions are 
multifaceted and target different locations in this matrix simultaneously. Unfortunately, 
non-adherence remains a formidable barrier in the management of HIV, resulting in the 
development of the transmission of HIV, in general, and transmission of drug-resistant 
strains ofHIV specifically. Despite substantial attention to adherence in recent years, 
much more remains to be done to better understand and promote adherence to 
antiretroviral therapy (Ickovics & Meade, 2002). 
Paterson (2002) assessed protease inhibitor adherence with Medication Events 
Monitoring System (MEMS) in 99 subjects in a Veterans Affairs medical center and a 
university medical center. He found a highly significant relationship between adherence 
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and viral suppression at three months and noted that failure rates increased sharply with 
decreasing levels of adherence below 95%. Paterson also reported that physicians and 
nurses poorly predicted adherence for 41% and 30% of patients respectively. 
Several strategies may prove useful in fostering adherence to HAART in adolescent 
patients. Pugatch, Bennet, and Patterson (2002) conducted a pilot study to qualitatively 
identify major factors which may correlate with HIV positive adolescent adherence to 
drug regimens. Six HIV positive adolescents ranging in age from 16 to 24 were 
interviewed. For each patient data were collected by medical chart review, a brief 
questionnaire and a semi-structured interview. The major factors found to negatively 
influence adherence were: strong fear of social stigma relating to HIV disclosure, familial 
over-involvement in the regimen, a complex drug regimen, medication side effects, poor 
general knowledge about the HIV infection, and the quality of the doctor-patient 
relationship (Pugatch, Bennett, Paterson, 2002). 
There is no gold standard for monitoring adherence that can easily be 
implemented in clinical practice. A variety of methods have been used to measure 
adherence including serum blood levels, medication events monitoring systems (MEMS) 
that record pill-bottle opening to gauge adherence, and self-reporting questionnaires. 
Clearly, non-adherence is a problem with patients who are required to take HAART. 
The Family Practice Clinic 
Family Practice physicians, physician-assistants, and nurse practitioners have as 
their primary commitment the provision of patient-centered care, which is 
biopsychosocial-spiritual in nature. Family physicians receive 4 years of medical school 
training and three years of residency training in Family Practice, physician-assistants 
receive 4-5 years of bachelor level training in accredited P A programs in colleges or 
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universities, and nurse practitioners receive two to three years of master's level training 
in FP nursing. All of these providers also must pass a certifying examination and 
licensing examinations before they can practice medicine. After their training is 
completed, these provider can provide the full spectrum of care to their patients, 
including family centered prenatal and delivery care, GYN services, adult and child 
preventive serves, managing current and chronic illnesses, and teaching patients how to 
prevent or reduce the likelihood of further illness. In other words, family practice 
providers can provide continuity of care and preventive services to patients of all ages, 
both sexes, inclusive of medical, surgical, obstetric, pediatric, and geriatric addressing the 
needs of the whole person, biologic, psychological, social and spiritual concerns. In 
providing continuity of care, the family practice provider may provide the service directly 
or coordinate and co-manage the care with an appropriate specialist, with another partner 
in the group, counselor, or another community resource (University of Michigan, 2005). 
The family practice clinic is unique in the sense it is a specialty in which general 
medical care is provided to all age groups. The internal medicine practice or clinic 
specializes in the study of organs inside the body and diseases of these organs. The 
pediatric clinic cares for the development of children, usually from birth to 18 years of 
age. Psychiatry is the study and treatment of emotional, mental, and behavioral disorders. 
Gynecology is the study of the health care of women, including diseases and normal 
physical care of the female reproductive system. Obstetrics is the care of women and 
their fetuses during pregnancy and childbirth, and during he events that come before and 
soon after birth (Evergreen Health Care, 2005). 
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Conclusion 
Several authors have researched medication adherence in all chronic disease 
states. Non-adherence to medication is the cause of many reported deaths, also non-
adherence is ultimately expensive in the United States because of the loss of workdays 
and earnings. The number of doses taken and the impact of the medical diagnosis 
measure medication adherence. Reasons for non-adherence range from simply forgetting, 
too many pills, and intolerance of side effects caused by the medication. 
HIV positive patients who are on medication have been studies extensive. Most 
studies where conducted in large medical clinics or infectious disease clinics. Simoni 
(2003) study like many of the others, showed as many as 60% of people taking 
antiretroviral cocktails adhere to their medications less then 90% of the time. Dose effect 
studies indicate HIV positive people need to take their medicine at least 95% of the time. 
No study was uncovered that involved a small family practice clinic. The family practice 
clinic is a medical specialty in which general medical care is given to all ages and all 
disease states. HIV positive patients often seek all their health care at the family practice 
clinic. 
The literature review uncovered several issues needed to address the HIV positive 
person's medication adherence regimens, but not in the family practice setting. The 
educational opportunities, the patient's life styles and the drug side effects were also 
addressed in the literature review. However, they were all quantitative research. The 
method of this study is qualitative. 
CHAPTER 3: METHOD 
One of the most challenging aspects of treating patients who have HIV I AIDS is 
finding ways to increase adherence to the often-complicated medication regimen. Many 
studies have been conducted regarding medication adherence and particularly adherence 
to HIV related drugs. The literature review revealed that the HIV related adherence 
studies were conducted in large clinics, i.e.: University, VA Hospitals, and Infectious 
Disease HIV I AIDS Clinics. However, not all people who are infected with HIV seek 
medical attention at this type of clinic. Family practice clinics also care for the HIV 
infected patient. These clinics offer more than HIV I AIDS care. The family practice 
healthcare providers care for the patient's entire health care needs. This includes 
everything from the common cold to major chronic healthcare issues. There is a need to 
study the HIV patient and their medication adherence within the family practice clinic. 
It is not uncommon for the family practice healthcare provider to have longer 
patient-provider time. Because multiple healthcare issues are being cared for in the 
family practice setting, the health care provider may have more in-depth knowledge of the 
HIVIAIDS patient's and personal well being. This may make a difference in 
understanding the adherence problems noted in the literature review. 
The research question can be addressed; What issues need to be addressed in 
order for the HIV positive person to adhere to their medication regimen in the family 
practice setting. Along with answering this research question three sub-questions will bed 
addressed: What educational opportunities were available to the participants concerning 
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their drug therapy, What is the participant's day to day lifestyle, including routine 
schedule, and What side effects of HARRT most concern the participants? 
Research Design and Rationale 
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I explored the meaning of adherence and non-adherence to HIV medication. This 
study was a basic interpretive qualitative research design (Merriam, 2002). A central 
characteristic of qualitative research is that individuals construct reality in interaction 
with their social worlds. Constructivism thus underlies what is called a basic interpretive 
qualitative study. Here the researcher is interested in understanding the meaning a 
phenomenon has for those involved. Meaning however "is not discovered but 
constructed. Meaning does not appear in the object, merely waiting for someone to come 
upon it. .. Meanings are constructed by human beings as they engage with the world they 
are interpreting" (Crotty, 1998, p. 42-43). 
Phenomenology and symbolic interactionism also informs interpretive qualitative 
research. From phenomenology comes the idea that people interpret everyday 
experiences from the perspective of the meaning it has for them. Thus, drawing from 
phenomenology and symbolic interaction in particular, qualitative researchers conducting 
a basic interpretive study would be interested in ( 1) how people interpret their 
experiences, (2) how they construct their worlds, and (3) what meaning they attribute to 
their experiences. The overall purpose is to understand how people make sense of their 
lives and their experiences (Merriam, 2002). 
This basic interpretive study showed how HIV positive people interpret their 
experiences of taking their antiretroviral medications and what meaning they attributed to 
their experiences. The purpose was to understand the nature or identify the issues of 
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medication adherence issues with the HIV infected patient in the family practice setting. 
The data was collected from face-to-face interviews conducted over 30 to 60 minutes. 
Participants and Site 
The informants were purposively selected (Gliner & Morgan, 2000). This 
procedure was used to select a sample from the participants, or groups of participants that 
were judged to be appropriate or especially informative for the purpose of this research. 
The participants were handpicked from the accessible population using specific criteria. 
The participants were located through my professional, academic network. A 
letter of agreement from the organization, (family practice clinic) on letterhead was 
obtained. None of the participants were my family members, personal friends, or actual 
patients of mine. The formal setting of the interviews was on site at the family practice 
clinic on a scheduled date and time. All interviews took place in a private room. The 
participants all spoke English as their first language. 
The healthcare providers handed out an information flyer (see Appendix A) to 
prospective participants asking for their participation. The participants included were 
HIV positive patients who receive their total healthcare at a selected family practice 
clinic in a western state. They all have been HIV positive for ten years or greater and 
have been on Highly Active Antiretroviral Therapy (HAAR T) drug regimen for 5 years 
or more. All participants work full time in a variety of jobs and are not considered 
critically ill. 
After 15 participants were interviewed, I felt the information I was receiving from 
them became repetitive, and saturation had been reached. After I began to code the 
conversations I found saturation and repetitive themes began after the 1 ih interview and 
complete saturation occurred by the 15th interview. 
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The family practice clinic is located in an upper class, urban neighborhood in a 
mid-western state. The clinic is considered to be gay friendly and advertises in the local 
gay newspaper as a well-established diverse medical clinic, and HIV knowledgeable. The 
clinic cares for all age groups and all general healthcare issues. The clinic has a total of 
four healthcare providers. Three out the four providers are openly gay. Two of the 
providers are family practice physicians and two providers are mid-level providers 
(physician assistant and nurse practitioner). The clinic gives healthcare to nearly 3,000 
patients and approximately 1 ,200 of those patients are HIV infected. 
Data Collection 
The Colorado State University Human Research Committee application to use 
human subjects was competed and reviewed by the committee and principal investigator. 
The primary means of data collection was a semi-structured interview with open-ended 
questions that lasted approximately one hour and was audiotaped. Three of the 
participants refused to be audiotaped, so only handwritten notes were taken by me. Prior 
to the interview the participants were advised of the informed consent to participate in a 
research project and were required to sign the consent (see Appendix B). Participants 
were asked open-ended questions. The participants had the opportunity to elaborate as 
much as they would like on each question and to give the best answer they felt was 
appropriate. The following are the questions I asked each participant. 
1. What HIV educational opportunities are available to you? 
2. Explain the HIV medication opportunities available to you in the past 5 years. 
3. Where did you get the most HIV information regarding your medication regimen? 
4. How much Internet access do you have regarding HIV and HIV medication? 
5. What learning material is most useful to you? 
6. Explain your day-to-day lifestyle, including your routine schedule. 
7. Explain the ease or difficulty of remembering to take your pills on a timely 
manner? 
8. What concerns do you have while you are on HAART? 
9. Are meals routinely skipped during the day? 
10. What do you consider a meal? 
11. How much travel do you have, vacation or work? 
12. How does health insurance or the cost of your medication affect you and your 
lifestyle? 
13. What type of dietary restrictions are you presently on? 
14. What side effects have you experienced while on Highly Active Antiretroviral 
Therapy? 
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15. Which drug side effects are the most difficult to control or concern you the most? 
16. How many pills do you take daily and how often? 
17. Are you on other medications that are not related to HIV? 
18. If you were able to make changes to your medication regimen, what would they 
be? 
All participants were interviewed at the family practice setting during their 
routine three-month HIV I AIDS examination. Data was analyzed throughout the study. 
The data was coded according to the constant comparative method until themes began to 
emerge. 
After the interviews were conducted a copy of the participant's transcripts were 
given back to them for review. A new consent form was signed because the first consent 
did not give me permission to re-interview. The second consent allowed a re-interview 
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which helped me to uncover further research information, and it allowed the participants 
to determine whether they thought the information was accurate. 
Data Analysis 
From the principals of grounded theory, I attempted to derive themes by using 
multiple stages of data collection and the refinement and interrelationship of categories of 
information. Two primary characteristics of this design are the constant comparison of 
data with emerging categories, and theoretical sampling of different groups to maximize 
the similarities and the difference of information (Strauss & Corbin, 1990). 
Some design types in qualitative research have detailed protocols for data 
analysis. For example, Strauss and Corbin (1990) provided a series of data analysis steps 
that consist of open coding, axial coding, selective coding, and the generation of a 
conditional matrix. In this process, the researcher attempts to saturate categories by 
''constantly comparing" incidents with incidents until categories emerge and through the 
sampling of informants that will lead to the development of categories. 
The constant comparative method of qualitative analysis worked well to help 
analysis the collected data from the face-to-face interview of all participants. After I 
reviewed each interview, I started with a simple coding process of each transcript. This 
step starts by coding each incident into as many categories of analysis as possible, as 
categories emerge or as data emerge that fit into an existing category. Which meant I 
coded important comments from each answer that was given to me. The codes related to 
adherence. This step started to generate theoretical properties of the category. The 
analysts gave a full range of the types of categories and the dimensions. I then found the 
common themes. I re-coded the themes into three groups. This process started to change 
from comparison of incident with incident to comparison of incident with properties of 
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the category. This was the start of answering which the research questions. The three 
categories were educational opportunities, lifestyle and side effects. The third coding 
process was more specific to my research questions. This step of coding began to delimit 
two major categories. These categories were what shapes the nature of adherence and 
what motivates adherence or does not. The purpose of constant comparison method of 
joint coding and analysis is to generate themes more systematically. Two themes 
emerged. The first theme was welling being and the second theme was life long 
commitment. This method of comparative analysis is to be used jointly with the 
sampling, whether for collective new data or on previously collected or complied 
qualitative data. The constant comparative method is designed to aid the analyst in 
generating themes that are integrated, consistent, and plausible. Still dependent on the 
skills and sensitivities of the analyst, the constant comparative method is not designed to 
guarantee that two analysts working independently with the same data will achieve the 
same results: it is designed to allow, with discipline, for some of the vagueness and 
flexibility that aid the creative generation of theory (Glaser, 1967). 
Trustworthiness 
The trustworthiness refers to trusting the data and not the participant trusting the 
researcher. Trustworthiness of this study is very important and refers to the believability 
of the findings. The trustworthiness increases the study's validity and verification. This 
was established through member checking, researcher's biases, the confidence of safety, 
and deserving credibility (Merriam, 1998). 
Member checking was conducted by taking data and tentative interpretations back 
to the participants interviewed and asking them if they agreed with the results. This was 
done through out the study. While the researcher may have used different words, 
participants should be able to recognize their experience I the interpretation or suggest 
some fine-tuning to better capture their perspectives (Merriam, 2002). 
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The researcher's biases clarified any assumptions that were made prior to the 
onset of the study. Such as, directing the participants towards a particular course or 
answer. This allowed an open and honest narrative. Merriam (2002) states by identifying 
bias and monitoring them it sharpen the collection and interpretation of data. 
Safety is the state of being safe. This study exempts all participants from loss or 
the state of not being liable from danger or injury. The participants were not considered 
to have passed or failed in regards to their answers. This was made clear to everyone 
involved in this research. Psychotherapy was available to the participants if needed prior 
to and after the interview. 
More over the federal government has established regulations to protect human 
subjects in biomedical behavioral, and social research. Professional codes and federal 
regulation deal with issues common to all social science research, the protection of 
subjects from harm, the right to privacy, the notion of informed consent, and the issue of 
deception (Merrian, 1998). 
Credibility commands belief and was established through a personal journal that 
was kept during the process for personal reflections of each interview. This journal 
allowed the researcher to reflect on what questions or responses seemed 
comfortable/uncomfortable to both researcher and participant. Each participant was 
allowed to review his or her response to each question and make changes in their answer. 
No participant made any type of change to the transcription. Also a copy of the final 
report will be available to each participant. Each participant was given a fictitious name. 
The name is related to correct gender only. 
CHAPTER 4: FINDINGS 
Through a basic interpretive qualitative research design (Merriam, 2002) research 
was conducted to investigate the issues that need to be addressed in order for the HIV 
positive person to adhere to their medication regimen in a family practice setting. A 
central characteristic of qualitative research is that individuals construct reality in 
interaction with their social worlds. Constructivism thus underlies what Merriam (2002) 
is calling a basic interpretive qualitative study. Here the researcher is interested in 
understanding the meaning a phenomenon has for those involved. 
Meaning, however, "is not discovered but constructed. Meaning does not inhere 
in the object, merely waiting for someone to come upon it. ... Meanings are constructed 
by human beings as they engage with the world they are interpreting" (Cotty, 1998). Each 
participant was given an opportunity to voice his opinion and tell his personal story 
regarding the difficulty of adherence to an HIV medication regimen. Also, several 
questions where asked of each participant. It should be noted that each participant gave 
unique answers and each story was profoundly interesting and interestingly there was a 
common set of findings. 
Participant Adherence Stories 
Sam is a male in his late forties who was diagnosed with being HIV positive for 
greater than 10 years. He is self-employed and owns and operates a very successful 
business. He states he was in denial of his disease for the first year. He refused to take 
medications and was not willing to follow up with his doctor. He said he was angry at the 
·world due to his diagnosis. It was not until he became very ill that he decided it was time 
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to start medications. He feels the HIV medications have saved his life but he has had 
many complications with his drug side effects. He is presently on a simple drug regimen 
that consists of two pills in the morning with breakfast and two pills in the evening with 
dinner. He rates himself as being "about 95%" adherent to his medication regimen. He 
sometimes forgets the evening dose due to his busy work schedule. 
James is in his early thirties and states he has worked for the U.S. Post Office for 
1 0 years. He enjoys being a mail carrier because he loves the outdoors and the 
independence of his job. He was diagnosed being HIV positive when he was 25. He said 
it was a complete shock to him. He only had a few sexual partners prior to his diagnosis 
and he thought his sexual practice was safe. He said the worst part of being told you are 
HIV positive is telling your family the news. He has been on several different HIV 
medication regimens. He claims that he became resistant to the drugs because he did not 
take the disease seriously and had very poor adherence. He stated, "I only took the drugs 
when I felt like it." He now says he has a better understanding of the disease process and 
only misses a few pills a month. 
Patrick is a male in his late thirties who recently moved from California to 
Colorado because of a job transfer. He was diagnosed with HIV seven years ago. He said 
he remembers the date, time, and place well. It was a major lifetime change. Prior to his 
diagnosis he called himself a "carefree type of guy." He had several sexual partners but 
never thought he would contract HIV. He started HARR T five years ago and states he 
tries to be as adherent to his medications as possible, but due to his business travel he 
either forgets to pack his medications or does not have time to take them. He hopes now 
that he has moved to Colorado his traveling will decrease and he will be better about 
taking his drugs. 
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Joe states he is a landscape architect. He said he could only have a job that gives 
him the freedom of being outside. In his words, "If I had to be indoors all day and wear a 
tie, I would die." He was diagnosed being HIV positive when he was 30 years old. 
However, he has only been on HARRT for 5 years. He said he did not start medications 
early in his diagnosis because he knew it would be a lifelong commitment and he was not 
prepared for that type of commitment. He feels he is very adherent to his medications," I 
never leave home without them." He did have issues with side effects when he first 
started to take the drugs. He once again experienced the side effects when his regimen 
was recently changed. He claims the side effects lasted about two months. 
Fred is a restaurant owner. He works 12 hours a day and usually does not get too 
much time for anything else. He said he was 45 years old and has been HIV positive for 
12 years. He has been off and on HARRT for several years. His lifetime partner is also 
HIV positive. He can recall days when he was very ill due to his illness and he can recall 
many days that he was ill due to his medications. Because he has a very busy work 
schedule he has told his doctor that he would only take HIV medications that were easy 
to take and only once a day. He has told his doctor that he refuses to take any medication 
that would cause severe fatigue or nausea. He states he is about 95% adherent to his 
present HARRT regimen. Because he deals with the public so much he also refuses to be 
on any medication that could cause body changes. He once was on a medication that 
caused severe diarrhea, which made his workday difficult. Presently he is having 
problems with his weight. He is 6'2" and only weighs 145. His doctor has told him that 
he may have to start on growth hormone therapy, which may interfere with his daily 
lifestyle. He stated he understands that HIV is a lifelong commitment, but feels it is more 
of a punishment. 
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Gerald claims he can tell you the exact day he was infected with HIV. He has 
been infected with HIV for 1 0 years. His lifetime partner is also HIV positive. He met his 
partner at a support group. Prior to meeting his partner he felt since he had contracted the 
disease, he would always be alone. His medication regimen is somewhat complicated 
since he has to take some of them on an empty stomach and some of them with food. 
Also, his medications are taken three times a day. Presently he remodels homes for a 
living and can set his own hours of work. 
Paul is the lifetime partner of another participant. He said he agreed to participate 
in the research study because his partner encouraged him to. This participant is a CPA. 
He has five very busy months out of the year and then in his words, "relaxes and gets 
ready for the next tax season." Like his partner, he is 43 years old and has been HIV 
positive for 1 0 years. He is very conscious of any body changes and his well being. He 
takes several types of vitamins and mineral supplements. He said he works out at the gym 
up to five times a week. He is also very interested in his blood counts each visit. He 
reported that he keeps a book of all his records and past and present medication regimens. 
He loves to travel on his free time. However, he does not like to travel with his 
medications. He was once stopped at the airport and his luggage was searched. Be was 
taken into a private room until proper medical authorities could identifY his medications. 
He hates to miss his medications because he usually has the side effect of nausea if he is 
not consistent. He said he has seen several doctors because of his disease and has finally 
found the healthcare provider he can trust. 
"Finding out" is what Jess said he is always worried about. He is in his late forties 
and states he always worries that someone at his workplace will find out he is HIV 
positive. He works at a bank and has been with the same banking service for over 20 
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years. He repeatedly complains about the inconvenience of his HIV medications. If he is 
not worrying about someone finding out at work he is worrying about getting sick. His 
health and well being are very important to him. He has been HIV positive for at least 12 
years. He states he does not smoke or drink alcohol because he does not want his immune 
system to get weak. His HIV medication regimen is twice a day. On his business trips he 
hides his drugs to avoid anyone asking him questions. He states he is very proud of his 
accomplishment and wants to be around for a long time. He claims to be 100% adherent 
to his medications. 
Thomas was very eager to be interviewed. He is a very thin athletic guy. He 
usually has his bicycle helmet with him because he prefers to ride a bike than drive a car. 
This participant is 43 years old, but gets compliments all the time about how young he 
looks. He has been HIV positive for 8 years and on medications for at least 5 years. He 
states he had a very rough time with the mediations when he first started taking them. He 
suffered from severe fatigue and nausea. His lifetime partner died of complications due to 
AIDS five years ago. He says he has seen what HIV/AIDS can do to a body and he will 
try anything and everything to prevent the tragedy of AIDS. He still has problems with 
remembering to take his medications everyday. 
Joshua is the oldest participant in this study. He frequently stated his age during 
the interview as 58. He says he cannot remember not being HIV positive. In reality, he 
has been positive for 19 years. He contributes his long HIV life to his constant awareness 
of well being. He is moderately overweight, does not exercise; however, he does not 
drink alcohol or smoke. He claims the only thing he does correctly and on a regular basis 
is take his medications. He can recall the days when there were not a lot of choices in 
regards to HIV medications. He said during his interview that when he was first 
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diagnosed with HIV 19 years ago, he was told to go home and prepare to die. He knew 
immediately he would not let the disease or any doctors tell him how to live his life. "I 
am 1 00% adherent to my HIV medications. Always have been and always will be." He 
also takes several daily dietary supplements. He sold his dry cleaning business three years 
ago and has started to travel. During his HIV history he has had difficulty with different 
medication regimens. He is presently on a twice a day regimen, but also takes 
medications to control his blood pressure and elevated cholesterol. He said his medicine 
cabinet looks like a pharmacy. 
The youngest participant is Zachary. He stated he was only 30 years old and has 
only been HIV positive for 10 years, but feels much older and feels like he has been HIV 
positive most of his life. He has been working as a flight attendant for the past six years. 
He started HARR T immediately after being diagnosed. He was shocked to find out he 
was HIV positive. At 25 years old, he thought he was too young to contract such a deadly 
disease. He had a good job, his family was well respected in the small community where 
he grew up, and HIV was only seen in the poor minority population. He has experienced 
many different side effects of the HIV medication, which have interfered with his work 
performance. He feels he has his medications under control and his side effects. 
Andrew is in his early fifties. He said he has been working for an advertising 
agency for many years. His job takes him to various parts of the country. He has been 
HIV positive for 10 years. This participant likes to lift weights as part as his exercise 
regimen. His face is thin, most likely due to the HIV medication he is on. He is well 
aware that he has had body changes since being diagnosed as HIV positive. He is not 
happy with current HIV regimen and plans to switch drug plans on his next office visit. 
He said he is simply on too many pills. He has friends who only take one or two pills a 
day and he wants an easier regimen and one with fewer pills. This participant said he 
feels HIV and his HIV medications run his life for him. 
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Casey is 39 years old and travels from the western slope of Colorado for the HIV 
care. He does not feel comfortable with the healthcare providers in his town. He works 
from his home and does computer consulting. He states he likes computers more then he 
likes humans. He has been HIV positive for 7 years. His former significant partner was 
HIV positive also. He is presently single and says it is difficult to date when you have 
HIV hanging over your head. He started HIV medications immediately after finding out 
he was positive, but two years later he stopped all medications to try an alternative 
holistic approach. Within two years his viral load had tripled and his immune system 
began to fail. He realized he had to make a lifelong commitment to the therapy and 
started up on a new and easier drug regimen. He claims to be at least 95o/o adherent to his 
therapy. 
"'I was 21 and dumb when I contracted HIV ," stated Kevin. He is now 41 years 
old and feels he is doing very well physically and mentally. "I have been HIV positive for 
20 years and it has not been easy." He was diagnosed with AIDS when he was 30 years 
old. He states he refused to take his medications because of side effects. He states the 
drugs interfered with his social life. He had returned .to college and felt the mediations 
caused him to be too fatigued to study. He took no medication for several years before he 
developed a pneumonia that was related to AIDS. He is now on his fourth HARR T 
regimen. He said he has graduated from college and works as a store manager for a home 
improvement company. 
Austin stated he was a travel agent. He loves to travel but hates to take his 
medications with him. He has been HIV positive for 10 years. He found out he was 
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positive when he went to a Sexual Transmitted Disease (STD) clinic. He said he did not 
tell anyone for two years. He finally went to his primary healthcare provider and began 
therapy. "I was concerned about my future and well being so I thought it was time to let 
someone else in on my secret." He states he never felt sick until he started the HIV 
medication. Eventually the drug side effects lessened. He started a support group for 
other HIV infected persons and an HIV newsletter that has a mailing list of over 900. He 
feels the more informed a person is in regards to HIV the more adherent and safe their 
lives will be. 
All 15 participants have a different story regarding their HIV disease and the 
antiretroviral medications they're presently on. An issue they all have in common is they 
all have had problems adhering to the drug regimens. They agree that the educational 
opportunities have greatly increased regarding the medications, but still find they battle 
problems such as drug side effects, frequency of taking the medications, and the amount 
of pills they have to take. These HIV infected participants have very active lifestyles. 
Their adherence issues center on their well being and the acceptance of HIV as being a 
lifelong commitment. 
Two Broad Contextual Themes 
Two themes appear to capture the meaning of adherence and non-adherence. 
Adherence is important to the well being of the HIV infected person and adherence is a 
lifelong commitment. These are driven by lifestyle and drug side effects. 
Well being 
Several of the participants stated they wanted to improve their lives. Joshua stated 
he never thought he would have to commit to taking medication for the rest of his life. 
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His lifestyle had completely changed once he started HAART. He felt as though he has to 
plan his day around taking his medications. 
I take my medication everyday because I don't want to get sick. I want to lead as 
normal a life as I can. My well being is not only important to me but also to my 
lifelong partner. (Joshua) 
My family depends on me to be healthy, because I am the primary financial 
provider for them. Without my income we would be on welfare. (Sam) 
It is not socially acceptable to be sick all the time. So I take my medications and 
adjust my lifestyle to accommodate my medications. (Fred) 
Seeing HIV in a more positive light contributes to the well being of the infected 
person. Sam stated he describes being HIV positive as a challenge rather than a threat. 
For instance, he associates it with a greater psychological well being which results in a 
lower level of depression. Other factors such as his social support and the ability to cope 
with his disease contribute to his good overall mental health. 
I was in a down hill lifestyle. I partied every night. Some times waking up in 
places I had know idea how I got there or where I was. Once I found out that I 
was HIV positive, my well being completely changed. It was a major wake up call 
to me. I began to eat healthier, I started to exercise and I paid more attention to 
my job and family. I am now on HARRT and try to be adherent to the medication. 
(Zachary) 
It was not until I was diagnosed being HIV positive that I started to take care of 
my self both physically and mentally. (Fred) 
Living with HIV does not mean you can't enjoy your life. (Austin) 
Living healthily and finding a balance can helps the HIV infected person to enjoy 
each day to the fullest. (Andrew) 
Many participants in this research project voiced their concerns about medication 
adherence and how it is related to mainly other well being factors such as exercise, 
nutrition, and the reduction of stress in their life. They agree that basic exercise is 
important for everyone, no matter what your physical condition. In addition to toning 
muscles and improving strength, exercise can greatly improve the immune system and 
help you feel better about yourself, which is especially beneficial for those living with 
HIV. 
It seems that when I exercise regularly, I also take my medications on a regular 
basis. I just feel better about myself and want to continue to look and feel good. 
So I guess that makes me want to be more adherent to my HIV medications. 
(Andrew) 
I have chosen an exercise program that I enjoy and incorporate into my regular 
routine. It is as simple as walking, lifting weights, and swimming. It makes me 
feel good about myself and in return I am more adherent to my HIV medication 
regimen. (Thomas) 
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While some stress is actually necessary for you to function at your best, too much 
takes a mental and physical toll. Several participants said they have learned to manage 
stress levels to prevent anxiety, depression and other mental health issues. 
There are times I am so stressed out because of work or personal reasons; I simply 
forget to take my medications. That is when I know I need to get more focused. 
Stressing about work has gotten me trouble more then once regarding my HIV 
medications. (Paul) 
I am seeing a psychotherapist right now to help me with my stress and other 
mental health issues. He too realizes how important it is for me to adhere to my 
medications. When I am overwhelmed or slipping into a depression, I am less 
likely to take my medications. (James) 
I am hopeless in remembering to take my HIV drugs if I start to have anxiety 
attacks due to stress. I have learned to seek help when this happens. Also I have 
learned to set a time frame, then block out when I will accomplish certain tasks. 
(Fred) 
Part of well being is good nutrition. The participants were concerned about eating 
well balanced diets and taking their medications. Joshua said he was always confused 
about which pill he was supposed to take on an empty stomach and which pill he was 
suppose to eat something first. 
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I have begun to work closely with a dietitian and personal trainer. I want to be in 
the best health as possible. That n1eans eating right, exercising and being adherent 
to my medication. (Thomas) 
Another part of well being that emerged during the interviewing process was the 
necessity of planning. While it may sound obvious, many participants said they find 
themselves running short of one or another drug for a variety of reasons. This was often 
because of poor planning. 
I get my medications mailed to me through a mail order pharmacy in a different 
State. I just take it for granted that the warehouse will mail my drugs on time. 
There have been times when I have ran out of medications before the new 
shipment has arrived. (Fred) 
I live in a small town and sometimes the local pharmacy does not have my HIV 
available when I need them. So I have to wait for the pharmacist to reorder the 
drugs. That could take up to three days. (Casey) 
Some drugs have different storage requirements than others, so the participant's 
planning must also address the storage needs. Fred said he puts aside a full week's supply 
of medications in an accessible place right after getting his drugs, and then starts using 
the rest of the his supply. This creates an e1nergency stash should unforeseen 
circumstances cause his basic supply to run short. 
A few participants expressed their general well being as changing for the better 
since they were diagnosed with HIV and having started HARRT. They felt they took 
their general good health for granted, and did not give it much thought. A few exercised 
daily and tried to eat the right foods, but never thought about the consequences of 
contracting a chronic and possibly fatal disease such as HIV. Since being diagnosed with 
HIV and having to take handfuls of pills they find themselves being more conscious 
about what they eat, where they travel, and other medication they may have to take. They 
no longer consider a simple cold a simple cold. They realize that since their immune 
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system is compromised they have to increase their healthcare awareness. A simple head 
cold can now lead into serious respiratory complication. 
Paul explained how his well being and HIV medications are related. He stated the 
main thing to understand is what the treatment options are and how to strike a balance 
between controlling HIV and maintaining a good day-to-day quality of life. By 
preserving the health of the immune system so it can fight disease HIV treatments can 
keep people well and active both now and in the future 
Lifelong Commitntent 
The outlook on HIV disease has gone from a death sentence to one of guarded 
optimism. HAART has produced substantial improvements in viral blood levels, illness 
episodes, quality of life, and death rates. This all comes from being committed to taking 
medications for the rest of your life. As Paul stated, ''I take my medications to live to see 
another day." 
The participants are well aware that missing just two drug doses can result in 
increased levels of virus in the body or resistance to the drug, derailing their 
effectiveness. They state the healthcare providers constantly remind them that 
maintaining HIV control requires a near perfect score in drug adherence. But some drug 
regimens for HIV are hard to stick to. The drugs can be difficult to tolerate. In addition, 
some regimens require upwards of 20 pills per day, pills that must be refrigerated or 
taken at particular times during the day or pills that must be taken with or without food. 
The participants want to have the "perfect score," but find the level of difficulty is high, 
and the risk of failing is even higher. 
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The participants voiced their concerns about having to take medications on a daily 
basis. However, they realize that once they start the medications, it is a commitment for 
life. 
Once I accepted the fact that I was HIV positive, I had to work on the fact that I 
would eventually have to take medications for the rest of my life. It is a 
commitment you hate to accept. I delayed starting medications as long as I could. 
I knew it would possibly slow down my busy lifestyle. (Jess) 
I have been on HIV medication for a long time and everyday I wish I did not have 
to take the drugs but it is my disease and it is not going away very soon. (Joshua) 
The participants agreed that managing HIV was a lifelong commitment; meaning 
the disease was not curable and it needs to be handled like any chronic disease. As one 
participant stated, his routine health exams were essential and preventive medicine was 
more important then ever. 
I am HIV positive and will be that way for the rest of my life. It is up to me to 
stay well, follow the advice of my doctor, take my medications, and prevent 
further damage to my body. (Jim) 
It frustrates me to think that I will have to take some type of medication for the 
rest of my life. This is the result of my past reckless lifestyle. I am now committed 
to stay healthy. It is my disease. I will not allow it to control me. (Zachary) 
Sam is a healthcare professional. He states he looks back at his entire HIV 
experience as being educational. He has had several therapy changes and has dealt with 
his own issues of how many times a day he has to take his medication and whether he 
needed to take it with food or not. However, he also deals with other HIV infected 
patients every day and he feels he can relate to what they are going through. It helps him 
realize that being HIV positive is a lifelong commitment to taking pills and staying 
healthy. 
Adherence is the key to a successful drug regimen. If a person is willing to take 
their medications as prescribed every day, then they're more likely to keep the 
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viral levels down in their body and have a more successful therapy. Any time 
anybody slips up, and people do slip up. There have been times where I've missed 
a dose myself, and sometimes things happen where you just can't help it. I've had 
several patients come into my workplace that have had various and sundry issues 
with taking the mediations that have been prescribed for them. They need to try 
the medication first if they haven't ever been on it before. They need to try it first 
to see if it'll work. Not everybody will experience the same side effects from the 
same mediation. Not everybody will experience side effects at all. I always end up 
telling them that this is a lifelong commitment, and you don't always get it right 
on the first try. (Sam) 
Most of the participants stated they refused to start a HIV medication regimen 
until they absolutely had to. They knew it would be difficult and once they started they 
were committed to the therapy. Typically the medications will be dosed two or three 
times a day. When the mediation has been prescribed to be taken twice a day the patient 
should try to take it every 12 hours. If their instructions are to take it three times a day, 
they should take it every eight hours. 
I feel if the doctor is going to prescribe a medication for me and he wants me to 
take it for the rest of my life, then he better make sure that the drug only has to be 
taken once a day. Any more than that and I'll forget taking it. (Fred) 
Setting up a good relationship with the healthcare provider is critical for 
maintaining adherence and plays a role in the lifelong commitment ofHIV therapy. 
Healthcare provider variables that affect adherence include whether the provider 
developed trust with the patient. Many of the participants voiced appreciation toward the 
healthcare provider who takes the time to develop a tailored treatment ~Ian to fit their 
lifestyle. They want a provider who has a good treatment alliance with them, one who 
telephones the patient at critical times, and who helps develop the patient's belief in the 
mediation regiment effectiveness. Patrick said his first doctor did not seem committed to 
taking care of the HIV infected patient and that made him feel less willing to commit to 
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the treatment of HIV. Once he found a doctor whom he felt was committed to the 
treatment he then felt committed to take the medications as instructed. 
I have been told several times by my doctor not to miss any doses of my HIV 
1nedication regimen. However, that is not as easy as he thinks. I always tell him if 
he took these drugs as long as I have he would skip a dose once in a while too. 
(Joshua) 
I know the importance of taking my medications daily and not missing a dose, but 
after a while you just want to take a break from the drugs. (Joe) 
I stopped taking my medication last summer because I was going to be out of the 
country. I figured it is my disease and I will have it the rest of my life so I'll take 
breaks when I want to. (Kevin) 
The HIV positive person who missed or stopped taking their medications did not 
feel sick iinmediately. They stated they felt fine without taking their medications. 
However, many patients stated they learned the hard \vay about stopping or missing 
doses. 
I stopped taking my medications. I did fine for over a year, and then I began to 
lose weight and developed a cough that would not go away. My HIV blood work 
was drawn and my viral levels had drastically increased and my immune system 
had crashed. I ended up in the hospital with a life-threatening pneumonia. I 
learned the hard way. I now know HIV is a lifelong commitment and my goal is 
to stay healthy. (Patrick) 
Stopping and starting my HIV drug regimen did not mean anything to me until I 
discovered that I had developed resistance to many of the drugs. The virus had 
mutated, which caused many of the drugs to become ineffective to the HIV. I am 
now on a multiple drug regimen, which is not easy to take, but it is my fault for 
not being adherent to the simpler regimens. (Kevin) 
The participants seem to have a good understanding about their future and the 
importance of taking their medications on a daily basis. They want to improve their lives 
by better understanding the disease and being proactive with their health. 
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Issues Related to Well being and Lifelong Commitment 
Despite the grave consequences of non-adherence to HAART, control ofHIV is 
only maintained effectively if treatment is not interrupted, respecting not only the number 
of pills, but dosage conditions. A treatment regimen can be complex and several areas 
need to be considered with regards to adherence failure. Description of the patient's HIV 
educational opportunities, their day-to-day lifestyle, and the medication side effect 
emerged from the participant's stories. 
HIV Educational Opportunities 
Participants in this research study have been infected with HIV for several years. 
They have been on some type of antiretroviral drug therapy for at least five years. The 
participants agreed that the opportunities have improved over the past five years. Several 
of the participants believed the community and the healthcare professionals have become 
more educated regarding HIV because the disease has been around for a while. Some of 
the participants stated that they believe people want to know more about HIV I AIDS and 
are not afraid to ask questions about it. The private organizations such as Colorado AIDS 
Project have spent more money along with the government to educate the general public, 
the infected patient, and the healthcare workers. 
Several opportunities are available now. Unlike ten years ago when I had no place 
to turn to. The AIDS educational centers were hidden in back alleys and no one 
spoke of them. (Kevin) 
There are several AIDS Service Organizations available now. Even small towns 
have support groups you can attend to receive HIV information. (Gerald) 
It is wonderful the way time has changed the stigma of HIV I AIDS. You can even 
find AIDS in the local newspaper regarding support groups and information 
regarding HIV medication. (Austin) 
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Most of the participants have computer access and utilized the Internet almost 
daily to retrieve information about their medications or other HIV information. As Jess 
said, "'Who doesn't have a computer these days?" The Internet allows anyone the 
freedom of being anonymous. It gives the person the right to research any subject at 
anytime. James said he does not use the computer very much because he finds computers 
to be confusing; however, he does own one and uses it only for emailing and 
entertainment. The other participants utilize the Internet on a regular basis. 
I depend on the Internet for most of my HIV information. I don't always believe 
what I read, but at least it is easy to find the information. (Paul) 
I work in front of the computer all day, so it is easy for me to access information 
through the Internet. I even bring information to my doctors that I have found on 
the Internet. (Paul) 
Another common thread that was noted is the participants depend on their 
healthcare providers for information about their disease and the medications they are 
placed on. There are several other levels of the health care profession that have primary 
care of the HIV infected patient. In addition to doctors, these other health care providers 
often include Registered Nurses, Nurse Practitioners, Physician Assistants, public 
healthcare workers, and psychotherapists. James stated he depended on his doctor to keep 
up on all the latest HIV drug regimens and educational literature and then pass it on to 
him. Although this is an ideal concept, he said he realizes it is not always possible for the 
doctor to collect all the latest information and pass it along to his/her patients. The 
majority of the participants felt their health care provider gave them a good start in 
regards to the educational opportunities and information, but lacked with continuation of 
information or they had poor follow-up. Participants felt they need to stay up-to-date with 
the latest information regarding drugs, immunization, and general well being. 
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My doctor is wonderful and very up-to-date on HIV I AIDS. However he does not 
always pass along important information about my disease. I have to be very 
specific with my questions to him or I'll leave the office without new information. 
(Jess) 
In the beginning, my doctor( s) gave me a lot of information and pointed out the 
educational opportunities that were available to me. I depended on them to give 
me the most up-dated data. Although I still depend on them for this information, I 
now do my own data research. (Gerald) 
Support groups are another opportunity for the HIV positive person to get 
information about their disease and about the medications available to them. Several local 
and national groups advertise in the various newspapers and magazines. Austin stated he 
felt the support groups were more beneficial early in his disease process. They gave him 
the opportunity to meet other HIV positive people and to help him understand the 
importance of adhering to his medication regimen. There are many support groups 
available. Friends and family are just as important Outside support is very important to 
an HIV infected person. 
Colorado AIDS Project has been a major part of my life since I found out I was 
HIV positive. (Fred) 
I try to attend as much community based AIDS/HIV workshops as possible. (Joe) 
The majority of participants felt the pharmaceutical information was biased and 
over glamorized the particular product they produced; however, there were certain 
educational items that all participants appreciated, such as pill charts that showed the 
various HIV medications and the dosing regimens. Also the various adherence reminders 
such as the pillboxes. 
The majority of educational material that is given out by the pharmaceutical 
companies has a heavy emphasis on their product, and usually one-sided. 
(Thomas) 
The pharmaceutical companies have been very helpful in regards to sponsoring 
various AIDS awareness classes or workshops. (Sam) 
It is nice to know that the drug companies are involved with HIV education and 
helping with drug adherence issues. (Gerald) 
I like to attend the pharmaceutical company educational programs because they 
usually provide a meal along with the lecture and the program is free. (Fred) 
Lifestyles 
Everyone has a different lifestyle and the HIV infected patient seems to be no 
different. To put this section in context, early in the history of the HIV disease process 
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the infected person felt as though they were given a death sentence. Many gave up their 
jobs and careers and prepared for death. Several of the participants stated they were 
happy with all the HIV research with Highly Active Antiretroviral Therapy (HAART), 
because patients continue to function in society without difficulty and, more importantly, 
live long productive lives. Many of the research participants work jobs that require 
greater then 40 hours per week. A few participants stated they work two jobs primarily 
for financial gain. The participants felt it was important to remind me that being HIV 
positive does not mean you have to stay home all the time. It does not mean the person is 
always sick or even looks sick. The HIV person is on the go more now than ever. Many 
stated that being active has caused a problem with adherence because they simply forget 
to take their medications because they are too busy. Also the participants complained 
about the problems of storing the medications. Many medications require refrigeration, 
which hinders travel. 
My lifetime partner and I live a very active life. We both work greater then 40 
hours a week. We don't have time to be sick, yet sometimes we don't have time to 
take our medicine either. (Thomas) 
Travel is a major part of my life. I understand that treatment interruption can 
cause long-term problems, but I don't like to travel with my medications. (Austin) 
I don't get home until late and I travel a lot. Traveling with HIV medications is 
not always simple, and taking these medications on vacation is annoying. 
(Zachary) 
Sometimes I am just too tired to remember to take my medication. (Joshua) 
Most of the participants take more than ten pills daily. The complexity of the 
regimen served to be a barrier to adherence partly when the participant's understanding 
of the dosing requirements was to complex for them. The participants stated they 
preferred a once a day regimen or no more then a twice a day regimen. The number of 
pills taken daily did not seem to be a major factor to the decision of taking the 
medication. As Joe said, '"One pill or a handful, it really does not matter, it's the 
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frequency that is more important." Missing a dose or the daily regimen is not uncommon 
among the participants. The reason for missing a dose or interrupting HAART varied 
from simply "I forget" to ''sometimes I just don't want to take my medication." It was not 
uncommon to hear the below statements. 
I wish I did not have to take so many pills. (Kevin) 
A once a day regimen would be very helpful. (Joe) 
I am constantly forgetting to take my evening pills. I wish I could just take them 
all in the morning. (Joshua) 
Food restriction played an important role in their lifestyles and adherence. Many 
HIV medications have to be taken with food and a few should be taken on an empty 
stomach. Because of the food restrictions several participants reported that they missed a 
dose of medication because they missed eating or they had already eaten something. 
Many participants stated missing a meal was not unusual because of their busy lifestyle. 
Breakfast was the most commonly skipped meal. 
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I get so confused sometimes. One pill I am suppose to take with food and one I 
am suppose to take on an empty stomach. That means I am taking the medication 
at different times, which really means I am not really on a once a day regimen. 
(Kevin) 
I asked my doctor to put me on a regimen that did not require any food 
restrictions. (Thomas) 
I will sometimes skip my morning dose because I don't always eat breakfast. If I 
take the medication without food or breakfast, I became very nauseated. (Casey) 
Because HIV medications are extremely expensive, it is important to have health 
insurance. Many participants take additional non-prescription medications such as 
vitamins and dietary supplements. The non-prescription type medications are usually not 
covered by the traditional health insurance. These are considered "out of pocket" 
expenses. The participants in this research study work full-time and voiced the 
importance of good health insurance. 
Without health insurance, HIV prescriptions could cost a person $2000 to $3000 
per month. (Paul) 
Insurance is an important aspect of a good lifestyle. (Andrew) 
My out of pocket expenses for my HIV medication is $200 a month, and that is 
with insurance. I have no idea how much I would be paying if I did not have good 
health insurance. (Casey) 
Side Effects 
Both short-term and long-term side effects and toxicities were shown to be 
associated with HAART adherence. Short-term side effects included skin rash, 
nightmares, fatigue, and gastrointestinal effects such as nausea, and vomiting. 
Many participants reported having a skin rash the first month of starting a new 
regimen. The participants who were on the non-nucleoside reverse transcriptase 
inhibitors reported skin rashes. They were worried these skin rashes indicated an allergic 
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or hypersensitivity reaction. Not all patients experience rash but as one participant said, 
"It's simply embarrassing," other comments include: 
It is bad enough to experience toxic side effects of these medications, but to have 
a visually noticeable side effect such as a skin rash. You find yourself having to 
explain to other people what is wrong with you. (Sam) 
There are some medications I refuse to be placed on because I do not want to risk 
the chance of developing a severe rash. (Patrick) 
Certain antiretroviral medications have been known to cause strange dreams or 
even nightmares. Not all participants complained about this side effect. Many said they 
did not consider their dreaming to be nightmares, but very vivid, and colorful. Never the 
less, they did not feel they had restful nights. 
I remember not wanting to go to bed at night because I never know what to expect 
with my dreaming. I lay awake at night fearful of having some type of bizarre 
nightmare. (Sam) 
I was given fair warning from my doctor that I might experience strange dreams 
the first few weeks of my new HIV medication regimen, and he was correct. I still 
have very vivid dreams. (Sam) 
Fatigue was also included in the long-term side effects. Most of the participants 
complained about the continuous problem of fatigue. One participant said his friends 
always know if he stops taking his medication because his energy level increases and he 
is more social. 
It has never been clear to me why I am always so tired. My doctor said it is one of 
the major side effects of being on HIV medication. It is one I could do without. 
(Thomas) 
I worry that if I am this tired now, what will it be like when I am much older? 
Maybe by then they will develop a new drug that will not cause as much fatigue. 
(Gerald) 
Nausea and vomiting or gastrointestinal problems are the most talked about side 
effect and usually occurs when the participants first start a HAART regimen. Some HIV 
drugs cause nausea when taken on an empty stomach. Thomas stated he would skip a 
dose of his medication if he did not eat something just to avoid being nauseated. 
I still get nauseated during the day even after being on HAART for 5 years. 
However, it is more controllable now. (Sam) 
Supportive mediation has been prescribed to me just in case I get nauseated or I 
start to vomit. That just means another drug I have to take. It is never ending 
story. (Jim) 
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Other long term side effects or toxicity's the participants voiced a concern about 
were elevated cholesterol, and body changes. Some of the participants stated they never 
had a blood cholesterol problem until they started an HIV regimen that contained a 
protease inhibitor. They were not made aware of this possible side effect until they 
started to get reports back for their healthcare provider reporting the elevations. A few of 
the participants were aware of the possibility and asked for a regimen that had less 
potential impact on cholesterol. 
I went from normal total cholesterol of 150 to a cholesterol level of 250 with in 6 
months. This scared me so I stopped taking my HIV drugs for a few months. 
(Jess) 
I had read something about the possibility of my triglyceride blood levels 
elevating due to the HIV regimen I was on. This was a big concern to me since I 
already have a strong family history of cholesterol problems. (Joshua) 
I was not happy to find out my HIV medication that was suppose to save me from 
dying of AIDS could cause me to die of a heart attack because it elevated my 
cholesterol. (Kevin) 
The most talked about side effect attributed HAART is body fat redistribution or 
lipodystrophy. These body changes were given several nicknames, including "crix belly", 
"protease paunch", and "buffalo hump.'' The participants reported that fat is lost from the 
thighs, limbs and face, and accumulates in the trunk or at the base of the neck. 
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Interestingly, no one reported an increase of overall body weight or at least did not blame 
their HIV regimen on an increase of body weight. 
I have asked my doctor not to put me on any medication that would make me look 
like a freak. I would simply not take the drug if I developed a buffalo hump on my 
back. (Zachary) 
You can always tell if someone is on an HIV regimen that causes body changes. 
They usually have sunken cheeks and big round crix bellies. (Austin) 
I'll stop taking my medications if I ever start to notice body changes. (Kevin) 
The participants gave many reasons for their adherence or lack of adherence to 
their HAART regimens. They agreed that the educational opportunities are readily 
available from the Internet, their healthcare providers, and the pharmaceutical companies. 
The participants stated their lifestyles are no different then the non-infected person with 
the exception of having to take anti-HIV drugs and dealing with the drug side effects. 
Summary 
This basic interpretive qualitative research study addressed the issues regarding 
HIV medication adherence. This study took place in a family practice setting. Each 
participant interviewed was given the opportunity to voice opinions and give their story 
regarding being HIV positive and the HIV regimens they have experienced. Throughout 
the interviewing process two major themes were captured regarding adherence and non-
adherence to HIV medications. This included the importance of well being of the HIV 
infected person and the acceptance of the lifelong commitment. These two themes are 
driven by lifestyles and social acceptance. 
Regarding well being, the participants voiced their concerns and desire to remain 
as healthy as possible. Being HIV positive was viewed more as a challenge then a threat. 
If well being meant staying healthy, that meant basic daily exercise, decreasing stress in 
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life, and maintaining proper nutrition and diet. Another aspect of well being that helped 
enhance medication adherence was planning. Since many of the HIV medication are 
taken at various times of the day and quantities vary, planning the day, week or month is 
essential. Also planning for storage of the medication is important since some the 
mediations require refrigeration. 
HIV is no longer a death sentence. Until a cure is developed, it is treated like a 
chronic disease. Therefore acceptance of a lifelong commitment is essential along with 
understanding issues about the disease and the medications prescribep for treatment. The 
Internet access and other educational opportunities to learn about HIV and the 
medications have drastically increased in the past I 0 years. The HIV positive person 
wants to know as much as possible about their disease and expects to have a healthcare 
provider who they can trust and who is very knowledgeable in regards to HIV and the 
various medication regimens. 
The HIV infected persons lifestyle is no different than the non-infected person. 
They travel, work and enjoy life the same. The HIV mediation regimens can be 
complicated, but need to fit into their lifestyles too. These regimens need to have as low 
side effect as possible. These side effects include rash, nightmares, fatigue, 
nausea/vomiting, and elevated cholesterol and body changes. The healthcare provider in 
the family practice setting can address all these issues. 
CHAPTER 5: DISCUSSION 
The first case ofHIV was reported as early as 1952. At that time, virtually 
nothing was known about the virus that causes the disease, and there was little that 
clinicians could do to slow·its inevitable progression to AIDS, then death. There have 
been several changes since then, and though there is still no cure for HIV, the virus can 
often be controlled now with medications. These medications are known as HAART, or 
Highly Active Antiretroviral Therapy (Heilman, 2003 ). 
Despite the undoubted benefits of antiretrovirals, control of the HIV is only 
maintained effectively if treatment is taken without interruptions, respecting not only the 
number of doses and pills, but also the dosage regimen. Proper adherence is a key 
element in optimizing the efficacy of the drugs prescribed. Missing just t\vo drug doses 
can result in increased levels of virus in the body or resistance to the drug, stopping their 
effectiveness. Maintaining HIV control requires a near perfect score in drug adherence. 
However, some drug regimens are difficult to tolerate. Some require upwards of 20 pills 
per day. Some of the medications require refrigeration; some must be taken with food, 
and some on an empty stomach (Chesney, 2000). 
Adherence levels of greater than 95% are required to maintain virologic 
suppression. Nevertheless, actual adherence rates are often far lower; most studies show 
that 40% to 60% of patients are less than 90% adherent (Chesney, 2000). Adherence 
tends to decrease over time. Reasons for non-adherence range from simply "I forgot" to 
"intolerable side effects," to "they just don't fit into their lifestyle." 
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The purpose of this basic interpretive qualitative study was to explore the nature 
of non-adherence to HIV medications in the family practice clinic setting. It is not 
uncommon for the family practice healthcare provider to have longer patient-provider 
time. Because multiple healthcare issues are being cared for in the family practice setting, 
the healthcare provider may have more in-depth knowledge of the HIV/AIDS patient's 
well being; 
The literature review found authors predicting and analyzing reasons people in 
general do not adhere to their medication regimens. According to Robert Haynes ( 1996), 
patients may not comply with a medication regimen for several reasons. Non-adherence 
may be intentional or involuntary. Adherence may relate to the quality of information 
given, the impact of the regimen on daily life, the physical or the incapacity of patients, 
or their social isolation. Many interventions to overcome these impediments have been 
tried, but evidence of sustained success is scant. 
Simoni (2003) stated that the daily regimen for the cocktail or HAART is not 
quite as complicated today as it was when the therapy was first introduced. However, the 
side effects of the medications remain, and people may experience vivid nightmares, 
headaches, nausea, diarrhea, rashes, altered liver function, change in their body's fat 
distribution and elevated cholesterol levels. Simoni also states the most common reasons 
given for not taking medications was, "I just forgot." 
The Health Belief Model 
The Health Belief Model (Rosenstock, 1966) grew out of a set of independent, 
applied research problems with which a group of investigators in the Public Health 
Services were confronted between 1950 and 1960. Becker (1974) indicates that the 
theory and development of the Model grew simultaneously with the solution of practical 
problems. Two classes of circumstance should be described which were largely 
responsible for the type of model that ultimately emerged. These concern the setting in 
which research was required and the training and background experiences of those who 
participated in the development of the Model. 
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The Health Belief Model (HBM) extends the use of socio-psychological variables 
to the explanation of preventive health behavior. The model analyzes an individual's 
motivation to act as a function of the expectancy of goal attainment in the area of health 
behavior, (Rosenstock, 1966). Rosenstock stated that the HBH is derived from the social-
psychological theory of researcher's K. Lewin, and Marshall Becker who have suggested 
that the Model can be categorized as an "expectancy x value" theory, attempting to 
describe behavior or decision-making under conditions of uncertainty. The HBM, which 
is concerned with the subjective world of the acting individual, proposes the following 
theoretical conditions and components. Becker (1974) indicated that the first individual's 
psychological readiness to take action (adherence)is determined by both the person's 
perceived susceptibility or vulnerability to the particular condition awareness of well 
being issues, and by his perceptions of the severity of the consequences of contracting the 
condition (lifetime commitment). Second, the individual's evaluation of the 
efficaciousness (education regarding value of drugs) weighted against this perception of 
psychological (life style issues) and other barriers or costs side (effects). Finally, a 
stimulus or "cue to action" is needed as a trigger (education). 
The "cue to action," held as necessary for activating the readiness variables, 
appears to serve to make the individual consciously aware of this feeling, thus enabling 
him to bring them to bear upon the particular problem. 
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The HBM assumes that motivation is a necessary condition for action and that 
motives selectively determine an individual's perceptions of the environment. The 
concept of motivations is operationalized in the model's dual dimensions. The HBM 
assumes that motivation is a necessary condition for action and that motives selectively 
determine and individual's perception of the environment. The concept of motivation is 
operationlized in the model's dual dimensions (Rosenstock, 1966). 
It has been suggested by Becker (1974) that the HBM should be expanded to 
include a separate motivational variable representing the need or desire for achieving 
health-related goals by employing the concept of "General health motivation". According 
to his modification, motives are viewed as dispositions within the individual to approach 
certajn classes of positive incentives, and it is postulated that the desire of attain or 
maintain a positive state of health and to avoid a state of illness is dimension ofhealth 
motivation. 
Glanz (2002) states the HBM is based on the understanding that a person will take 
a health-related action (ie., use condoms) if that person: 
1. Feels that a negative health condition can be avoided. 
2. Has a positive expectation that by taking a recommended action, he/she will avoid a 
negative health condition. 
3. Believes that he/she can successfully take a recommended health action. 
A recent addition to the HBM is the concept of self-efficiency, or one's confidence I 
the ability to successfully perform an action. 
Evelyn B. Winfield and Arthur L. Whaley (2002) in their study tested an expanded 
version of the HBM in the prediction of condom use during vaginal intercourse among 
African American college students. Results from regression analyses indicated that only 
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the core HBM explained significant amount of variance in condom use. Perceived 
barriers and gender were the only significant predictors of condom use. Consistent with 
past research finding, high levels of HIV I AIDS risk knowledge was not significantly 
correlated with condom use. 
The Health Belief Model and Behavior Related to HIV Medication Adherence 
In comparing and contrasting the HBM to HIV and HIV medication adherence, 
this study found that two themes or elements need to be focused on and what drives the 
two themes/elements. The first theme was well being, driven by side effects of the 
medications. This is representing differences in degree of concern for the individual 
health matters. The second theme is the acceptance of lifelong commitment of the 
disease. This is driven by lifestyle. All are tied to educational awareness. 
A hypothetical model has been constructed relating the HBM to HIV medication 
adherence as found in this study, seen in Figure 1. This model can be useful as a rubric 
for further research on HIV positive patient related aspects of delivery of care, and avoid 
expenditure of large amounts of time and effort on additional examination of variables 
found in most instances to be related to adherence behavior. 
The Meaning of Adherence 
According to Sharan Merriam (2002), all qualitative research is interested in how 
meaning is constructed, how people make sense of their lives and their worlds. Here the 
researcher is interested in understanding the meaning a phenomenon has for those 
involved. The primary goal of a basic qualitative study is to uncover and interpret these 
meanings. Some disciplinary-based concept, model, or theory always frames the inquiry. 
Two themes capture the meaning of adherence and non-adherence. Adherence is 
important to the well being of the HIV infected person and adherence is a lifelong 
commitment. These are driven by lifestyle. 
Well Being 
Concerns about health matters 
Positive health activities 
Life changes for the better 
Presence of symptoms 
Life Long Commitment 
Acceptance of illness 












Figure 1. The Meaning of Adherence/Non-Adherence. 
HIV medications have only been available since 1987. Since I987, many 
pharmaceutical companies have researched and developed several new drugs. The goal 
for all HIV medication or antiretrovirals is to lower the HIV viral concentration in the 
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blood. Consequently, by lowering the viral load the HIV infected patient can live a longer 
and healthier life. Unfortunately many of the participants are not I 00% adherent to their 
medication regimen, (Bayer, 2002). 
Similar to what Bayer (2002) has reported, a few of the participants in this study 
have been taking HIV medications since they were first discovered to be useful in the 
treatment of HIV in I987. They admit they have not been I 00% adherent with their 
medications and the final outcome was poor viral suppression. 
66 
John Bartlet (2003) stated improving length and quality of life is the ultimate 
objective in treating people with HIV I AIDS. Without treatment, eventually the HIV 
infected person becomes seriously ill and death occurs. In my research, all the 
participants had a goal to improve the length and quality of their lives. They voiced their 
concerns and understanding that without medication treatment the end result for them 
would be death. 
According to Chesney (2000), patients find it easier to cope with their disease if 
they see it as an opportunity for personal growth or can attach some other positive 
meaning to it. Their perception of their disease might affect how well they stick to a 
medication schedule or avoid risky behaviors related to HIV infection. I found that the 
more information and the better understanding they had about their disease, the better the 
medication adherence. 
Basic exercise is important for everyone, no matter what your physical condition. 
In addition to toning muscles and improving strength, exercise can greatly improve the 
immune system and help you feel better about yourself, which is especially beneficial for 
those living with HIV (Williams, 2001 ). Two years later Flaheery (2003) stated that by 
decreasing stress and focusing on staying mentally healthy, adherence to the HIV 
medications improved. Also, good nutrition aids the immune system in fighting disease 
and strengthens the body in preparation for those medications that will help the HIV 
infected person to stay healthy. I agree with both researchers. The participants in this 
study explained to me that they try to be proactive in their healthcare by exercising on a 
regular basis and by having a healthy nutritional intake. They claim to have a better 
adherence to their medication when they feel good about themselves. 
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My study agrees with Hausman's (2002) observation that a stable access to drugs 
is critical for the participants to adhere to their medication regimen. People cannot stay 
on their medication if they don't have access to their medications. Many of the 
participants in my study are frequent travelers, either due to frequent vacations or work 
related. They stated they have a very difficult time remembering to take their medication 
while traveling or if they get too busy at work. I also found that the patients who have to 
refrigerate their medications are more likely to not to take the drugs with them if they are 
traveling. It was also uncovered that the patient who lives in a rural community has less 
access to the HIV medications and is more likely to miss doses due to simply running out 
of drugs and not having nearby access. 
My study agrees with Bartlet (2002) that adhering to an HIV drug regimen can 
pose tremendous challenges. Missing any two doses can result in increased levels of virus 
in the body or resistance to the drugs. No one can be sure how well clients follow their 
prescribed drug regimens. An adherence rate of 95% is considered necessary for viral 
suppression, but actual adherence rates are often far lower; most studies show that 40% to 
60% of patients do not take their medications as ordered 90o/o of the time. I did not 
uncover information regarding the length of time a patient becomes non-adherent to the 
time they are adherent again to their medications. This area of research needs to be better 
understood and researched. What my research does reveal is the HIV infected person can 
be just as active as the non-infected person and because of their active lifestyles the more 
non-adherent they become. 
Johnson and Volberding ( 1999) studied healthcare providers of HIV patients. 
Their research showed non-adherence could be frustrating for the healthcare provider and 
the patient. Some patients just can't seem to do it. They just cannot take their medication 
or they won't, so their viral load gets worse. As a healthcare professional/provider who 
cares for the HIV infected patient, I find it very frustrating and alarming to find out the 
patient is not taking their HIV medications as directed or has stopped taking them 
entirely. I have asked other providers how the non-adherence of their patients makes 
them feel and they too indicate they became very frustrated. Often the provider is not 
aware of the non-adherence until blood work is performed and the viral load has 
increased and the immune system begins to fail. I feel more research can be done with 
various HIV health care providers on how they cope with the frustration of the non-
adherent patient. 
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Today's effective treatment means that people with HIV are living longer, 
healthier lives than ever before. To live longer and healthier means to accept the lifelong 
commitment of the disease and medication adherence. But adhering to an HIV regimen 
can pose tremendous challenges. Some drug regimens for HIV are hard to stick to. The 
drugs can be difficult to tolerate. Missing doses of HIV medications is a big issue. The 
drugs are carefully dosed to maintain blood levels that will suppress the virus. The virus 
will be unable to replicate because of the drugs' actions. But if a person does not take the 
prescribed dosage, the drug level can fall and there will not be enough concentrate of the 
drug to inhibit the virus. Even if this information is given to the patient they still forget to 
take their medications or just stop taking them after a period of time (Paterson, 2002). As 
Paterson's (2002) research suggests, there are not immediate physical signs related to 
missed doses or someone stopping their medications. When a patient skips a dose it's not 
like a cold and their symptoms become worse or their health returns. There is not the 
immediate physical illness to remind them to take their medication. However, many 
patients stated they learned the hard way about stopping or missing doses. They 
69 
eventually became sick and were restarted on a more difficult drug regimen. The 
participants in this study have been HIV positive for 10 year or more which gives proof 
that the HIV infected patient can live long healthy lives. This could be due to better HIV 
medications, and I believe because the patients are now accepting HIV as a lifelong 
commitment. 
I believe that Jones (2002) research compared the closes to my research. His 
participants experienced six essential themes. The experience of"Becoming a Patient", 
dealt with the physical and psychological shift form being well to taking HIV 
medications, which caused the participants to feel ill. Becoming a Patient occurred for the 
study participants with the decision to start on HIV combination drug therapy. After the 
initial agreement to initiate HIV medication therapy, the participants had to deal with 
taking their medications. The experience of "~anaging and Being Managed by the 
Medications", incorporated the tremendous change in lifestyle that occurred because of 
necessary medication-taking behaviors and activities. "Coping With the Medications" 
involved strategies to facilitate long-term adherence to the HIV medication regimen. 
"Feeling Lousy", described experiencing side effects of the medications. "Negotiating the 
Hassles and the Cost", involved battling the system, including insurance companies and 
managed care. The attitude of a health maintenance organization (HMO) was perceived 
as an uncaring feeling of no emergencies. "Living Under a Dark Cloud", described the 
ever present fear of development of drug resistance, worry about the future, and the 
uncertainty of how long the mediation regimen would stay effective and keep the 
individual healthy. 
Similar to Jones, my research uncovers the initial agreement to initiate HIV 
medications and then facing the life long commitment and life style changes. The drug 
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side effects were addressed as they were in my study. However, Jones study was 
conducted in a large medical setting and total patient care was not provided to each 
patient. My study takes place in the family practice clinic were the patients total health 
care issues are addressed. I believe this is important since I have noticed an increase in 
HIV positive patients seeking their care at family practice clinic. 
In conclusion, the literature review and this study suggest that HIV patients 
sometimes simply forget to take their medications. My literature review uncovers very 
little information on the new lifestyles of the HIV infected patient. Bayer, (2000) does 
review the history of HIV including "The Dark Years, Fear, Impotence and Rejection" of 
the HIV positive patient. He address the life style changes from once know as a domed 
life style to one of active and well educated. My study also revealed the HIV infected 
patient is just as active in the community as the non-infected person. They travel and 
work the same jobs. The uniqueness of this study is how the lifestyles and acceptance of 
the lifelong commitment was researched in a small family practice clinic and these two 
themes influence adherence or non-adherence to the HIV regimens. 
Research Questions Answered 
This research project asks the question, "What issues need to be addressed in 
order for the HIV positive person to adhere to their medication regimen in a family 
practice setting." In order to answer the question, three other questions had to be 
answered. 
1. What educational opportunities were available to the participants concerning 
their drug therapy? 
The participants felt there were adequate educational opportunities. They believed 
the opportunities have increased over the past 5 to 1 0 years. Many stated they could 
remember having hunted for information regarding HIV, and particularly HIV 
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medications. Now, public classes and community forums are held on a weekly basis. 
Even popular magazines give some type of educational information. The participants are 
thankful for the educational opportunities the pharmaceutical companies provide. Also, 
the healthcare providers in the family practice setting are better educated on HIV and 
have up-to-date patient literature/books/fliers, which are readily available. Because most 
of the participants have computer access, the Internet has greatly improved the awareness 
and education ofHIV. 
The previous literature poorly addresses the question of educational opportunities. 
Although the several authors (e.g., Bartlet, 2003; Chesney, 2000; Johnston, 1999) 
addressed HIV I AIDS very well, including the history and patho-physiology of the 
disease, the patient opportunities were not covered very well. Schaffer (200 I) stated that 
if the patient understands the purpose of a drug and how the drug is to be taken, they are 
more likely to take it as prescribed. He states also that the patient is more likely to adhere 
to a regimen when the relationship with the healthcare provider is good. Researchers such 
as John Bartlet and Paul Volberding work in large infectious disease clinics. No research 
was uncovered regarding the patient in a family practice setting. Chesney (2002) has 
addressed the importance of various support groups and journal/magazines that address 
the HIV infected patient. She states support groups and journals such as POZ have 
become increasingly available in general stores and newsstands. Also, there has been an 
increase in advertising in the newspapers for public support group meetings. 
2. What is the participant's day-to-day lifestyle, including routine schedule? 
It is clear that the HIV infected patients can and do live normal lives. Just like the 
non-infected patient they work all types of jobs and are very active in the community. 
Being HIV positive does not stop the HIV patient from traveling/vacationing. The 
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participants stated it was a major problem traveling with their medications. Many times it 
was due to the simple problem of quantity or volume of medications they have to pack. It 
was stated several times during the interviewing process that they would rather stop 
taking their medications while traveling or vacationing because of the inconvenience and 
embarrassment of being stopped in the airport by the security guards. Traveling can be a 
problem because some of the medications require refrigeration. 
Jones (2002) did address the life style of his research participants. The nine 
participants were active full-time employed nurses. The nurses describes being HIV 
positive as being a life-changing experience. They improved their over-all well-being and 
·remained active in the community. 
Bayer (2000) has addressed the issue of day-to-day lifestyle of the HIV patient in 
his research. He stated the HIV infected patient today could live a normal lifestyle. In the 
past he would talk to his patients about death and illness. Now he talks about life. He 
talks about managing side effects and continuing a ''normal life." He states the HIV 
infected patient is now going back to school, traveling, exercising, and preparing for 
retirement. This is a drastic change from living in the 80s. 
3. What side effects of HAART most concern the participants? 
Many different side effects are associated with the use of anti-HIV drugs. The 
occurrence of side effects plays a large role in adherence to drug regiments, which in turn 
can impact the development of drug resistance. Short-term side effects that most 
participants complained about were skin rash, nightmares, fatigue, and gastrointestinal 
effects such as nausea and vomiting. Long term side effects that the participants voiced 
the most concern about was elevated cholesterol and body changes. Some of the 
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participants stated they would not take their medications because they feared heart 
complications or they feared unpleasant body changes. 
Medication side effects were well represented in the literature review. According 
to Cohen (2003), at least half of all people stop taking their medications because of side 
effects that typically include fatigue. During this research project an article by Liza 
Highleyman ( 1998) was uncovered about side effects associated with anti-HIV drugs. 
Her comments about side effects and drug adherence relate well to this research project. 
Many different side effects are associated with the use of anti-HIV drugs. The 
occurrence of side effects plays a large role in adherence to drug regimens, which 
in tum can impact the development of drug resistance. Side effects such as nausea 
and diarrhea, which affect drug absorption, can also contribute to drug resistance. 
The frequency and severity of side effects vary greatly from person to person. In 
some cases, side effects are worse when a drug is first started and may lessen over 
time. Side effects are often more frequent and more severe in people with 
advanced HIV disease who are more immunocompromised. However, people 
with HIV are often able to manage side effects so that they can benefit from 
potent anti-HIV treatment while maintaining a good quality of life. (p. 40) 
The issues that need to be addressed in order for the HIV positive person to 
adhere to their medication regimen in a family practice setting are complex. However, 
this study addressed the question well. The lifestyle of the HIV infected patient is no 
different then the non-infected person. The HIV infected person now lives long and 
healthy lives due to Highly Active Antiretroviral Therapy (HAART). This regimen of 
medication has become well accepted by the HIV positive person through the wide range 
of educational opportunities presently available to them. The more education provided to 
this patient, the greater the chance of medication adherence. When side effects of these 
medications are addressed along with possible prevention issues, adherence has 
improved. 
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In conclusion, the issues that need to be addressed in order for the HIV positive 
person to adhere to their medications in a family practice setting is a combination of 
understanding the educational opportunities, the patients lifestyle and the side effects that 
most commonly affect the patient. Since total patient care is given in the family practice 
setting, a pamphlet could be developed to address the two themes. 1.) The well being of 
the patient and, 2.) The life long commitment. This pamphlet could be in question and 
answer form, addressing the most common responses this research uncovered. This 
pamphlet can start an open dialog with the family practice provider and continue to 
address non-adherence issues. 
Implication for Practice 
The results of this study indicated that educational opportunity for the HIV 
infected person has greatly improved in the past 5 to I 0 years. The healthcare providers 
in the family practice clinic need to be abreast of what these opportunities are and 
encourage the patient to continue their HIV I AIDS education and understanding. Also, 
everyone has a different lifestyle and the HIV infected patient seems to be no different. 
As long as the disease itself is controlled, it should not handicap a person from living a 
healthy fulfilled life. Both short-term and long-term side effects can hinder the adherence 
of HIV medications; however,_ with the proper patient education the side effects can be 
reduced. The healthcare provider needs to be aware of the potential drug side effects of 
the anti-HIV medications and when ever possible, choose a drug regimen that fits into the 
patient's lifestyle. 
Two themes capture adherence and non-adherence. Adherence is important to the 
well being of the HIV infected person and is a lifelong commitment. This is driven by the 
life style of the participants and medication side effects. Improving length and quality of 
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life is the ultimate objective in treating people with HIV I AIDS. This disease is not a 
death sentence. HIV infected people live long and healthy lives. HIV is considered a 
chronic disease and the infected patient must make a lifelong commitment to control the 
disease and not let the disease control them. To do this the patient must make a 
commitment to adhere to their medications and be proactive with other healthcare issues. 
Other healthcare providers in the family practice settings who care for HIV 
infected patients should learn from this study that HIV medication adherence issues are 
more complicated than just pill burden and frequency. The HIV infected person does not 
sit around the house waiting to die. They travel and work and function in today' s society 
just like the non-infected person/patient. Since the family practice provider is caring for 
the entire healthcare of the HIV positive person, more time needs to be spent on 
discussing the lifestyle of each patient. When this issue was addressed with a healthcare 
provider, he stated he sometimes forgets to look at the whole picture. Because of this 
study he will begin taking more time getting to know his HIV patients, and "find out 
what makes them click." The family practice provider should learn from this study that 
the patient wants and needs to become more actively involved with choosing their 
treatment regimens. As one provider said, "It makes sense to me. It is their disease and 
they will more likely take the medication if they buy into it too." Since the family 
practice provider is taking care of the HIV infected person's entire healthcare, it is 
essential they keep up-to-date with all HIV regimens and help educate the patient. 
Recommendations for Future Research 
As a result of this study, a few recommendations can be made. This study should 
be replicated at much larger level. More than one family practice clinic can be involved 
and women should be included. Multiple case sampling adds confidence to findings. By 
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looking at a range of similar and contrasting cases, we can understand a single case 
finding, grounding it by specifying how and where and, if possible, why it carries on as it 
does. We can strengthen the precision, the validity, and the stability of the findings by 
following a replication strategy. If a finding holds in one setting and given its profile also 
holds in a comparable setting but does not in a contrasting case, the finding is more 
robust. The ""multiple comparison groups" used in a grounded theory work play a similar 
role (Miles, 1994 ). 
Although this study was designed as a basic interpretive qualitative research, a 
future design could be conducted as a grounded theory study. A grounded theory study is 
when the researcher attempts to derive a theory by using multiple stages of data 
collection and the refinement and interrelationship of categories of information {Strauss, 
1990). The grounded theory approach, particularly the way Strauss develops it, consists 
of a set of steps whose careful execution is thought to "guarantee" a good theory as the 
outcome. Strauss would say that the quality of a theory can be evaluated by the process 
by which a theory is constructed. Although not part of the grounded theory rhetoric, but 
because of the topic of this study, HIV, it is apparent that grounded theorists are 
concerned with or largely influenced by true meaning the world and, in this case HIV 
medication adherence. The researcher will use categories drawn from respondents 
themselves and which can focus on making implicit belief explicit. 
Two primary characteristics of this design are the constant comparison of data 
with emerging categories, and theoretical sampling of different groups to maximize the 
similarities and the difference of information (Creswell, 1994). 
Finally, this study can be narrowed down to a biographical study. A biographical 
study would look at an individual HIV positive person and his or her experiences before 
77 
their diagnosis of HIV and after. If an individual's history and lifestyle was followed, it 
may help explain why other HIV infected people are adherent or non-adherent to an HIV 
medication regimen. In a biographical study the life story of an individual is written by 
someone other that the individual being studied using archival documents and records. 
Subjects of biographies may be living or deceased (Denzin, 1989). 
Conclusion 
Adherence issues regarding HIV medications in the family practice setting is a 
complicated subject. There are many reasons why HIV infected patients on medications 
stop or skip does of medications. Several researchers have studied adherence issues for 
several years. The majority of studies uncovered in the literature review concluded that 
the drug side effects, pill burden (too many pills to take), and frequency of pill taking 
were the most causes of non-adherence. 
However, none of these studies were conducted in the family practice setting. 
This study revealed the HIV infected person is just as active with and within the 
community as the non-infected person, and HIV is treated as chronic disease and not as a 
death sentence. Both the family practice healthcare provider and the patient are better 
educated regarding HIV and the medications used for treatment. This study suggests 
adherence is under the influence of well being and the acceptance of being a lifelong 
commitment. The lifestyles of the patients need to be addressed with any HIV medication 
treatment, along with the potential side effects of these drugs. 
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APPENDIX A:HAART ADHERENCE STUDY FLIER 
84 
ATTENTION PATIENTS WHO ARE ON 
HIGHLY ACTIVE ANTIRETROVIRAL 
THERPY 
85 
A study will be conducted at Apex Family Medicine regarding 
medication adherence. We are looking for several patients who 
have been on HIV medications for five years or greater and are 
willing to discuss important issues regarding their medications. 
The study will consist of a 30 to 60 minute private interview. 
The information will be used as part of a research project 
being conducted by Peter Prutch, NP-C in partial fulfillment of 
his requirements for the Degree of Doctor of Philosophy at 
Colorado State University. 
Under the supervision of Don Quick PhD. Professor of 
Education at Colorado State University 
Confidentially will be honored. 
If you are interested in participating in this study, please 
contact Peter Prutch at (303) 321-0222 by March 20,2004. 
